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ABSTRACT:  
 
Abbott Molecular recently developed the rapid Vysis IntelliFISH Hybridization Buffer for use in 
fluorescence in situ hybridization (FISH) assays. The hybridization step in a standard FISH assay 
requires an overnight incubation, thus the turnaround time for a patient result is at least 24 hours. 
The IntelliFISH buffer was designed to reduce hybridization time of probes to target DNA to 
about two hours, allowing the entire assay to be performed in a single day. A review of 
methodologies and commercial products has highlighted the importance of hybridization kinetics 
to a successful FISH assay. The purpose of the research was to investigate whether the 
IntelliFISH buffer is an appropriate reagent for producing high quality FISH results in a single 
day within a clinical laboratory environment. A method comparison experimental approach was 
used to evaluate signal intensity and hybridization specificity on a subjective scale with outlined 
criteria for each scale score. The IntelliFISH hybridization buffer was tested on a total of fifty 
cases representing direct processed chorionic villus, formalin-fixed paraffin embedded (FFPE) 
tissue, peripheral blood and bone marrow samples using a variety of probes, and it produced 
varied results dependent on sample type and probe type. This research was sufficient for 
validation of the Vysis IntelliFISH Hybridization Buffer. Since the conclusion of the study, the 
BWH cytogenetics laboratory has started to edit the SOPs for some routine FISH studies to 
include a rapid hybridization. Faster turnaround times will provide patients with numerous 
benefits and will improve patient and physician satisfaction overall.  
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INTRODUCTION (1) 
Fluorescence in situ hybridization (FISH) is an assay that combines molecular and 
cytogenetic technologies to test patients for specific chromosomal aberrations. In traditional 
FISH methods, there is typically an overnight hybridization step that results in a turnaround time 
of at least 24 hours for the test. The Abbott Molecular website boasts that their new product, the 
fast working Vysis IntelliFISH Hybridization Buffer, incorporates novel chemistry to reduce the 
hybridization time to only two hours, making FISH “easier, faster, [and] smarter” (Vysis 
IntelliFISH Solution, n.d.). The product was purchased by the Clinical Cytogenetics Laboratory 
at Brigham and Women’s Hospital (BWH) in Boston, MA, with the expectation of improving the 
quality of patient care by reducing the turnaround time of FISH assays.  
BACKGROUND AND LITERATURE REVIEW (2) 
Fluorescence in situ Hybridization (2.1) 
 In FISH, fluorescently labeled probes are used to identify entire chromosomes, regions of 
chromosomes and genes which, given the appropriate conditions, may reveal specific 
chromosomal abnormalities. FISH is an advantageous technology because conventional 
cytogenetics can only be performed on dividing cells in metaphase, but FISH can be performed 
on both metaphase preparations and on non-dividing interphase nuclei, including formalin-fixed 
paraffin embedded (FFPE) tissue samples (Zhao et al., 2017). Since dividing cells are not 
required for FISH, the technology is useful for examining a large number of cells even in 
samples with a low (or no) mitotic index. With specifically designed probes, FISH can be useful 
for quickly detecting aneuploidy and rearrangements that are too small to identify using 
conventional karyotype analysis such as microdeletions and cryptic rearrangements involving the 
subtelomeric regions of chromosome arms (Mascarello et al., 2011). The resolution of FISH is 
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lower than that of microarray-based technology, but FISH has the advantage of being able to 
detect balanced chromosomal rearrangements, which microarrays cannot (Shaffer et al., 2007). 
 Every laboratory that performs FISH has a specific standard operating procedure (SOP), 
but the general technical steps for a FISH experiment are essentially the same. The first step 
requires the fixation of a sample onto a slide. Samples are processed differently depending on the 
sample type and whether the sample is being used for metaphase or interphase FISH. Once the 
samples have been fixed onto slides, the slides are dehydrated in a graded ethanol series. A 
fluorescent probe diluted to an appropriate concentration in a hybridization buffer is selected to 
target the chromosome or region of interest. The probe and the sample DNA are denatured and 
incubated underneath a sealed coverslip at an appropriate temperature to allow for hybridization 
of the probe to the target DNA. Following hybridization, the slides are washed to remove 
unbound probe, counterstained, and subsequently analyzed using epifluorescence microscopy.  
 The hybridization of the DNA probe to the patient sample is traditionally performed at 
37ºC for 18-24 hours to allow for maximum annealing of the probe DNA to the target DNA. The 
time required for hybridization is a technical limitation of FISH assays, which results in a 
turnaround time that is at least 24 hours. By substituting a standard buffer with a fast working 
buffer, the hybridization step could theoretically be reduced for overall improved patient care. 
Abbott Molecular released a product, the fast working Vysis IntelliFISH Hybridization Buffer, 
which, according to the company website, incorporates novel chemistry to reduce the 
hybridization time to only two hours, making FISH “easier, faster, [and] smarter” (Vysis 
IntelliFISH Solution, n.d.).  
Kinetics of DNA Hybridization (2.2) 
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In fluorescence in situ hybridization assays, hybridization is defined as the reannealing of 
two strands of denatured DNA to form a double stranded DNA (The Association of Genetic 
Technologists, 2017). The rate of hybridization is evaluated in terms of hybridization kinetics. 
Hybridization reactions are elaborate and not yet well characterized, but the reagents and 
chemistries in a hybridization buffer can provide some clues. Evidence has shown that the 
intermediate states of nucleic acid duplex formation determine the kinetics of DNA 
hybridization, and as such the simple and traditional two-state model is no longer used to define 
DNA duplex formation (Yin and Zhao, 2011). The complexity of intermediate states has 
hindered researchers’ abilities to draw definitive conclusions regarding the rates of DNA 
hybridization (Yin and Zhao, 2011).  
As of yet there is no perfect model for studying the kinetics of DNA hybridization, but 
3SPN.1 and oxDNA are two models that have aided in our current understanding (Doye et al., 
2013; Ouldridge et al., 2013). One suggested mechanism of hybridization using the 3SPN.1 
model is the “sliding” of the strands up and down until proper alignment is reached, at which 
point a strand must often “flip” to completely hybridize (Sambriski et al., 2009). Another 
mechanism for hybridization of random sequences proposed by Sambriski et al. (2009) using the 
3SPN.1 model is the formation of key base pairs between two strands of DNA before the rest of 
the strands “snap” into the hybridized state. The single stranded DNA in the 3SPN.1 model have 
structural and mechanical properties that are similar to a double helix (Doye et al., 2013), but in 
the nucleus of a cell, single stranded DNA molecules can unstack, thereby becoming non-helical 
and far more flexible than the stiff double helix of double stranded DNA (Lodish et al., 2000). 
The rigid structure of single stranded DNA is a major shortcoming of the 3SPN.1 model, because 
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the model cannot properly characterize all mechanisms of DNA hybridization (Doye et al., 2013; 
Ouldridge et al., 2013).  
The second model that has been used to study the kinetics of DNA hybridization is 
oxDNA, which better represents the flexibility of single stranded DNA and therefore has been 
used to explain other mechanisms for DNA duplex formation (Doye et al., 2013). Ouldridge et 
al. (2013) used the oxDNA model to suggest that there is not a single transition state, but instead 
a transition pathway with multiple intermediates. The model supports a previously suggested 
mechanism of hybridization in which initial contacts are formed between two strands of DNA, 
followed by the “zippering” of the remainder (Craig et al., 1971). Direct evidence for zippering 
of individual nucleotides is the discrepancy between the melting profiles of identical sequences 
of DNA that are labeled with different Fluorescence Resonance Energy Transfer (FRET) pairs at 
different locations, suggesting the presence of intermediates in hybridization (Yin & Zhao, 
2011). However, researchers using oxDNA went beyond the standard mechanism to show that 
hybridization is not always so simple (Craig et al., 1971; Doye et al., 2013; Ouldridge et al., 
2013).  
Craig et al. (1971) explain that zippering requires relatively unstructured stands, and in 
order for zippering to be successful, a strong initial base pair must form quickly so that more 
base pairs will subsequently form. Often even after initial contact of a few base pairs, the DNA 
strands will not transition to form a double stranded molecule because the initial contact is not 
strong enough and the strands dissociate before more bases will pair (Craig et al., 1971). The 
initial contact typically forms towards the end of the strands, but a full duplex is more likely to 
form when the initial contact is towards the center of the strands (Ouldridge et al., 2013). 
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Interestingly, the dissociation, or denaturation, of DNA duplexes is well understood, but the 
association, or formation, of the double stranded molecules is not as straightforward.  
DNA dissociation requires a relatively large positive activation enthalpy because many 
bonds have to be broken in order to separate the double stranded molecule (Rauzan et al., 2013), 
explaining why dissociation rates increase when temperature increases. Chen et al (2007) suggest 
that association is a more complicated process and cannot be explained using simple 
thermodynamic principles at the level of secondary structure. The nucleation step of DNA 
hybridization involves the formation of initial base pairings, as described previously with the 
zippering mechanism of hybridization (Chen et al., 2007). Gao et al. (2006) state that even when 
the initial base pairs have attractive interactions and the thermodynamic properties strongly 
suggest that hybridization will take place, the base pairs often dissociate and hybridization fails 
because the secondary structures of the strands do not promote hybridization. Therefore, both the 
secondary structures of the DNA strands and the strength of the initial base pairings dictate 
whether hybridization will continue or the strands will dissociate with increased temperature 
(Craig et al., 1971; Gao et al., 2006). An association reaction is non-Arrhenius, with a negative 
activation enthalpy that becomes more negative as temperatures increase (Ouldridge et al., 
2013). 
Guanine (G) and cytosine (C) pairing is more stable than pairing between thymine (T) 
and adenine (A) because G-C pairing creates three hydrogen bonds while A-T pairing creates 
only two hydrogen bonds (Pullman & Pullman, 1959). Thus, when the initial contact is G-C-rich, 
the probability of complete hybridization increases due to the increased stability of the initial 
contact, and assuming that initial contacts form at approximately the same rate, the rates for full 
hybridization are fastest for the G-C-rich sequences and slowest for A-T-rich sequences (Gao et 
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al., 2006). The sequence can also affect the rate of hybridization in regards to internal 
displacement depending on where in the sequence the misaligned pairing took place and how 
strong the initial contacts are (weak contacts will dissociate before internal displacement can take 
place, and strong contacts may not easily break to resolve the misalignment) (Ouldridge et al., 
2013). 
3SPN.1 and oxDNA have also been used as models to describe the hybridization of 
repetitive DNA. Sambriski et al. (2009) used the 3SPN.1 model to propose a mechanism of the 
duplex formation in which there is an initial binding event followed by the “slithering” of 
repetitive DNA strands to match up the remaining base pairs. Ouldridge et al. (2013) used 
oxDNA to propose multiple alternative hybridization mechanisms that repetitive sequences may 
take in order to form a duplex, and showed that when the reactant concentration is low, the 
alternative pathways actually accelerate the rate of association. The research was performed 
using oligonucleotides but it is proposed that the alternative pathways likely make a strong 
contribution to the association of longer strands of DNA since the probability of misaligned 
binding is higher in longer stands (Ouldridge et al., 2013). Alternative pathways initially start 
similarly to zippering with a few base pairs forming a contact, but base pairs commonly misalign 
in repetitive sequences leading to internal displacement, or the rearrangement of the same two 
strands without detaching (Ouldridge et al., 2013). Mechanisms that have been proposed for 
internal displacement include the “inchworm” mechanism, in which the misaligned strands form 
a “bulge” loop that is resolved by breaking the bonds from the initial contact so the bulge can be 
passed through the original duplex like an inchworm, and the “pseudoknot” mechanism where 
the two single stranded tails of the misaligned strands bind together, resulting in a pseudoknot, 
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which can be resolved to form a duplex after one of the contacts displaces the other (Ouldridge et 
al., 2013).  
The rate of association is not only dependent on the specific nucleotide sequence, but also 
on other factors of the environment in which the hybridization is taking place. The ideal 
conditions for hybridization are still being studied and are not well defined yet, but some 
research suggests that one chemical may promote an increased rate of hybridization: guanidine 
thiocyanate (Thompson & Gillespie, 1987). Guanidine thiocyanate has historically been used in 
nucleic acid isolation methods for its ability to be an extremely strong denaturing agent and 
when used at high concentrations, its ability to essentially inactivate all cellular enzymes, 
including RNAses (Mölder & Speek, 2016). Thompson & Gillespie (1987) showed that DNA-
RNA hybrids formed ~50-100x faster in the presence of guanidine thiocyanate than in 50% 
formamide solution proposing that guanidine thiocyanate can promote DNA association because 
the chemical reduced the melting temperature of the hybrids and allowed for the optimal 
hybridization temperature.  Tyagi et al. (1996) showed that guanidine thiocyanate is also useful 
for lysing cells, releasing nucleic acids from cellular matrices, unwinding DNA molecules, 
relaxing RNA secondary structures, and preventing denatured cellular debris from interfering 
with the hybridization reaction.  
Two commercial hybridization buffers currently used in laboratory FISH procedures are 
Abbott Molecular’s CEP (centromere enumeration probe) buffer which has been optimized for 
use with CEPs, and LSI (locus specific identifier) buffer which has been optimized for use with 
LSI probes. Both buffers are used regularly in routine FISH procedures and require overnight 
hybridizations, and therefore are considered standard hybridization buffers. The chemical 
difference between the CEP and LSI buffers is unclear because the buffers share a Material 
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Safety Data Sheet (MSDS), suggesting the compositions are the same. An Abbott Molecular 
standard hybridization buffer, according to the MSDS, contains 60-100% formamide by weight, 
and smaller amounts of sodium dextran sulfate, sodium chloride and water (See Appendix A). 
The IntelliFISH rapid hybridization buffer contains 34.20% formamide and 12.30% guanidine 
thiocyanate (See Appendix B). Interestingly, the IntelliFISH buffer MSDS does not have any 
information regarding the remaining ingredients in the buffer even though the formamide and 
guanidine thiocyanate make up only 46.5% of the buffer combined. Matthiesen & Hansen (2012) 
have shown that lower formamide concentrations increase signal intensities observed in a FISH 
assay, and standard formamide concentrations can prevent rapid hybridization kinetics. Since 
guanidine thiocyanate is the only major ingredient that is present in the rapid IntelliFISH 
hybridization buffer but is not present in a standard hybridization buffer, I propose the addition 
of guanidine thiocyanate with the decreased formamide concentration may be responsible for the 
IntelliFISH buffer’s claimed increased association reaction rate (the specific chemical reaction or 
reasoning is not provided by Abbott Molecular).  
Overall, the kinetics of DNA hybridization is very complicated. The rates of association 
can depend on the strength of the initial contact, the secondary structures of the DNA strands, the 
transition pathways, internal displacement in cases of misaligned strands, as well as the DNA 
sequence itself. The conditions of the reaction, including temperature and buffer composition 
have also been shown to affect the rate of the reaction. It is important to note, however, that most 
of the DNA hybridization kinetics research done thus far has been performed using 
oligonucleotides, which are short strands of DNA, and may not be directly applicable to longer 
strands of DNA. More research is required to better understand DNA hybridization kinetics, 
which will allow for optimization FISH assays and improvement of turnaround times.   
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MATERIALS AND METHODS (3) 
Cohort (3.1) 
In this study, a cohort of fifty cases was divided into eight sample categories (Figure 
3.1.1). Sample types and probes were chosen based on frequency of use in the BWH 
cytogenetics laboratory and the potential advantages of improved turnaround times to patients 
that receive the testing.  
Figure 3.1.1: Flowchart of sample categories and probes being used with each case for this study. “Prenatal Probes” include a 
probe mixture for chromosomes 13 and 21, and a probe mixture for X, Y, and 18. 
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Prenatal FISH (3.1.1)  
 The probes evaluated for use on CVS and peripheral blood interphases with the Vysis 
IntelliFISH hybridization buffer were the standard laboratory prenatal panel; chromosomes 13, 
18, 21, X, and Y. Probes for the DiGeorge syndrome region (HIRA/ARSA), SRY, and 
subtelomeric regions of chromosomes 1p, 4p and 17q were selected for use in metaphase FISH 
on peripheral blood samples. FISH is frequently used for prenatal genetic testing, especially 
following abnormal screening results. Although it is recommended that any major decisions 
regarding the pregnancy are not made until the karyotype result is released, FISH can be very 
helpful because it has a faster turnaround time than chromosomal analysis and patients will 
receive a preliminary result from FISH before the karyotype result is ready. The Vysis 
IntelliFISH hybridization buffer has the potential to make the turnaround time even faster, 
therefore improving patient care by releasing the preliminary report earlier.  
 DiGeorge syndrome is a congenital disorder that is characterized by neural-crest-related 
developmental defects. DiGeorge syndrome is the result of a microdeletion of TBX1 (Gene ID: 
6899) which is located at 22q11.21. At the exact same chromosomal location lies the HIRA gene 
(previously known as TUPLE1; Gene ID: 7290). Microdeletions cannot typically be detected 
using conventional cytogenetics, but a FISH probe that targets the HIRA gene and the ARSA gene 
(Gene ID: 410) located at 22q13.33 can show if there is, in fact, a microdeletion of the critical 
region.  
 Sex chromosome abnormalities are fairly common in prenatal samples. The SRY gene 
(Gene ID: 6736) is located at Yp11.2 and is responsible for initiating male sex determination. 
Using a probe for the SRY gene in conjunction with a probe for the centromere of the Y 
chromosome can show cryptic rearrangements that may result in an ambiguous phenotype, such 
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as an XY fetus with a deletion of the SRY gene, or presence of SRY in an XX fetus. Using 
subtelomeric probes for other chromosomes, such as chromosomes 1p, 4p and 17q, can help to 
quickly determine if there is aneuploidy following an abnormal screening result. Deletions of 
subtelomeric regions may also result in phenotypic abnormalities, and are more easily detectable 
using FISH. 
 Prenatal samples are particularly time sensitive because patients are often faced with 
difficult decisions regarding the pregnancy following the return of an abnormal result. A rapid 
hybridization protocol using the IntelliFISH buffer allows for a faster turnaround time, thus 
giving patients more time to think about options and less stress waiting for the return of results.  
Double-Hit B-cell Lymphomas (3.1.2) 
 The Vysis IntelliFISH hybridization buffer was evaluated for use with probes for genes 
involved in double-hit (DH) B-cell lymphomas. DH B-cell lymphomas are those in which there 
is a chromosomal breakpoint involving the MYC locus at 8q24.21 (previously known as CMYC; 
Gene ID: 4609), in combination with another recurrent rearrangement (Aukema et al., 2016). 
MYC is a transcription factor that regulates the transcription of specific target genes. It is a proto-
oncogene, so mutations or rearrangements involving the gene often result in issues with cell 
cycle progression and apoptosis. Typically, the second rearrangement involves a translocation 
that juxtaposes the IGH locus at 14q32.33 (Gene ID:3492) with a proto-oncogene. IGH codes for 
the immunoglobulin heavy chain, which is involved in antigen recognition in the immune 
system. When chromosomal rearrangement involves in the juxtaposition of IGH with a proto-
oncogene, it usually results in continuous activation of the proto-oncogene (now an oncogene), 
and therefore neoplasia.  
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 Common translocation partners of IGH typically include BCL2 and BCL6. BCL2 (Gene 
ID: 596), located at 18q21.33 codes for a protein that blocks apoptosis of some cell types, such 
as lymphocytes. When juxtaposed with IGH, BCL2 is continuously activated and apoptosis rates 
decrease. BCL6 (Gene ID: 604), is located at 3q27.3 and it codes for a protein that acts as a 
sequence-specific transcription repressor and regulates the transcription of B-cell IL-4 responses. 
After a translocation involving BCL6 and IGH, BCL6 is activated and constantly suppresses IL-4 
responses. Though very rare, IGH may also be juxtaposed to CCND1 in DH B-cell lymphomas. 
CCND1 (Gene ID: 595) is located at 11q13.3, and codes for a cyclin protein which acts as a 
CDK kinase regulator. Since CDK kinases are required for the cell cycle G1/S transition, 
overactivity of CCND1 due to a rearrangement with IGH can disrupt cell cycle progression.  
In the case of DH B-cell lymphomas, the breakpoint in the MYC gene is considered the 
“first hit,” and the juxtaposition of IGH with an oncogene is often considered the “second hit.” 
IGH-BCL2 rearrangements are the most common second rearrangement in DH B-cell 
lymphomas, followed by IGH-BCL6 rearrangements (Aukema et al., 2016). In the BWH 
cytogenetics laboratory specimens are first tested for a MYC rearrangement, and if it is positive, 
are then tested for BCL2 or BCL6 rearrangements. Since involvement of CCND1 is uncommon 
in DH B-cell lymphomas, it is not included in the typical DH B-cell lymphoma test in the BWH 
cytogenetics laboratory. 
Although DH B-cell lymphoma chromosomal rearrangements are typically detectable 
using conventional cytogenetics, FISH is more advantageous. Many DH B-cell lymphoma 
samples are FFPE tissue samples, which cannot be used in conventional cytogenetics, but are 
compatible with FISH. If the neoplastic cells are only a small percentage of the sample, FISH is 
more likely to find abnormal cells because more cells are scored in FISH than in conventional 
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cytogenetic analysis. Finally, cryptic rearrangements are possible in DH B-cell lymphomas, so 
FISH may be able to detect an abnormality that is not visible using conventional cytogenetics.    
As with all neoplasias, the earlier a diagnosis is made, the better the patient's chances of 
remission and survival. DH B-cell lymphoma testing in the BWH cytogenetics laboratory calls 
for two consecutive hybridizations if the sample is positive for a MYC rearrangement, so the 
protocol using the standard buffer takes a minimum of 48 hours. With the IntelliFISH buffer, two 
consecutive hybridizations can be performed in a single day, so even if the sample is positive for 
a MYC rearrangement the patient can get results the same day. The use of the IntelliFISH buffer 
to improve turnaround times would allow the patient to start treatment earlier, therefore 
increasing the chances of reaching remission. 
Chronic Myeloid Leukemia and Acute Promyelocytic Leukemia (3.1.3) 
The laboratory often receives samples that are to be tested for cytogenetic changes that 
are characteristic of chronic myeloid leukemia (CML) and acute promyelocytic leukemia (APL), 
and the results of the tests will affect the treatment that the patient will receive. The Vysis 
IntelliFISH hybridization buffer has the potential to improve patient care by getting results back 
faster so that a treatment plan can be set or altered.  
CML is a chronic myeloid proliferative disorder of the hematopoietic stem cell. All CML 
patients have a translocation between chromosomes 9 and 22 at bands q34 and q11, respectively, 
that results in a very small chromosome 22 that has been named the Philadelphia chromosome. 
The rearrangement brings together the ABL1 gene (Gene ID: 25) located at 9q34.12 with the 
BCR gene (Gene ID: 613) located at 22q11.23. ABL1 is a proto-oncogene, and its protein product 
is a tyrosine kinase that is involved in multiple cellular processes, including cell division, 
adhesion, differentiation, and response to stress. Interestingly, the function of the normal BCR 
O'Connor 
15 
 
gene product is unclear, but in the Philadelphia chromosome it is known to keep ABL1 activated 
which results in issues with the cell cycle. Although all CML patients have the t(9;22) at least at 
the molecular level, the translocation has also been found in other diseases, so the translocation 
alone is not diagnostic of CML (Atlas ID: 1117). Typically, the cytogenetic results are used in 
conjunction with the clinical features of the patient to determine a final diagnosis. If a patient's 
clinical features strongly suggest CML but a t(9;22) is not found using conventional 
cytogenetics, FISH is used to determine the presence of a cryptic rearrangement that may result 
in the fusion gene. 
APL is a type of acute myeloid leukemia with at least 20% blast cells in the bone 
marrow. There is a translocation between chromosomes 15 and 17 at breakpoints q24 and q21, 
respectively, that is diagnostic of APL. The translocation juxtaposes the PML gene (Gene ID: 
5371) at 15q24.1, with the RARA gene (Gene ID: 5914) at 17q21.2. The PML protein product 
functions as a transcription factor and a tumor suppressor by regulating the p53 response to 
oncogenic signals. The protein product of the RARA gene is a retinoic acid receptor that is 
involved in the regulation of development, differentiation, apoptosis, granulopoiesis, and 
transcription of clock genes. When the translocation brings the two genes together, PML 
represses transcription of the RARA protein which results in the arrest of myeloid cell 
differentiation at the promyelocytic stage (Atlas ID: 1240).  
FISH testing for the fusion gene is very important because patients with the fusion gene 
can be well treated with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). Patients with 
similar symptoms but without the fusion gene do not respond to ATRA and ATO, so the 
diagnosis, treatment course, and prognosis are different. It is therefore very important that 
patients get results back as soon as possible so the course of treatment can be determined and 
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started, which is why the Vysis IntelliFISH hybridization buffer would be very helpful in 
improving the quality of patient care.  
Preparing Probe Mixtures (3.2) 
 A laboratory can buy FISH probes that are pre-mixed and ready to use, but many labs 
prefer to make the mixtures themselves for a number of reasons, such as cost savings on 
infrequently used probes or a making specific mixture that is not commercially available. The 
IntelliFISH probe mixtures used were prepared using the formulas listed in table 3.2.1 
(Information about each probe can be found in Appendix C). The standard probe mixtures were 
prepared according to the BWH cytogenetics laboratory SOP and include a probe:dH2O:buffer 
ratio of 1:1:8. When developing the formulas for the IntelliFISH buffer, dH2O was not included 
because it was unclear if the addition of water would affect the buffer's efficacy. The 
probe:buffer ratio used for the IntelliFISH mixtures was 1:9 so that the probe made up 10% of 
the mixture regardless of which buffer was used. The mixtures that include a standard 
hybridization buffer were mixed using a vortexer, but the Vysis IntelliFISH hybridization buffer 
is very viscous and vortexing is not recommended by the manufacturer, so the IntelliFISH 
mixtures were slowly and repeatedly pipetted up and down to mix. All probe mixtures were 
stored at -20ºC until the samples were ready for hybridization.  
Vysis IntelliFISH Hybridization Probe Mixtures 
Sample Category # Probe Formula 
1 and 6 Chromosomes X, Y, and 18 (Prenatal) 3 µL CEP X Orange 
3 µL CEP Y Green 
3 µL CEP 18 Aqua 
21 µL IntelliFISH Buffer 
1 and 6 Chromosomes 13 and 21 (Prenatal) 3 µL CEP X Orange 
3 µL CEP Y Green 
3 µL CEP 18 Aqua 
21 µL IntelliFISH Buffer 
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2 and 7 BCL2 12 µL LSI BCL2 Break Apart 
108 µL IntelliFISH Buffer 
3 and 7 BCL6 12 µL LSI BCL6 Break Apart 
108 µL IntelliFISH Buffer 
4, 7 and 8 MYC 7 µL LSI MYC Break Apart 
63 µL IntelliFISH Buffer 
5 HIRA/ARSA 1 µL LSI HIRA 
1 µL LSI ARSA 
8 µL IntelliFISH buffer 
5 SRY + Y 1 µL LSI SRY + CEP X 
1 µL CEP Y 
8 µL IntelliFISH buffer 
5 Subtelomere 1p 1 µL TelVysion 1p 
9 µL IntelliFISH Buffer 
5 Subtelomere 4p 1 µL TelVysion 4p 
9 µL IntelliFISH Buffer 
5 Subtelomere 17q 1 µL TelVysion 17q 
9 µL IntelliFISH Buffer 
7 and 8 IGH 2 µL LSI IGH Break Apart 
18 µL IntelliFISH Buffer 
7 and 8 IGH/CCND1 2 µL LSI IGH/CCND1 - XT Dual Color Dual Fusion 
18 µL IntelliFISH Buffer 
8 BCR/ABL1 1 µL LSI BCR/ABL Dual Color Dual Fusion 
9 µL IntelliFISH Buffer 
8 PML/RARA 1 µL LSI PML/RARA Dual Color Dual Fusion 
9 µL IntelliFISH Buffer 
Table 3.2.1: Probe mixtures using the Vysis IntelliFISH Hybridization Buffer 
 
Slide Preparation and Pretreatment (3.3) 
 FISH is performed on samples that have been processed and fixed onto slides. With the 
exception of sample category #6, two slides were made for all cases so that one slide could be 
hybridized using each buffer. For sample category #6, four slides were made per case so that the 
two prenatal probe mixtures were on separate slides, and each probe could be hybridized using 
both buffers. The slides used for CVS FISH have two wells, so both prenatal probe mixtures 
were hybridized to the same slide for category #1. 
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 The technologists in the prenatal team at BWH cytogenetics laboratory processed the 
samples and made the slides for sample category #1 according to the laboratory’s SOP for CVS 
samples (See Appendix D). Sample categories #2 and #3 are made up of the extra FFPE tissue 
slides for cases that were pre-processed according to the laboratory's SOP for DH B-cell 
lymphomas and negative for the MYC rearrangement (See Appendix E). Specimens for sample 
categories #5-8 were fixed pellets that had been processed according to the laboratory’s SOP by 
the peripheral blood and bone marrow teams and stored at 4°C (See Appendices F-J). Since the 
samples had already been cultured and harvested, the fixed cell pellets were ready to be dropped 
onto slides as described in the laboratory's SOP (See Appendix K). All slides except for those in 
sample category #4 were manually pretreated for FISH according to the laboratory's respective 
SOP (See Appendices E and L-N). 
 Slides for sample category #4 were prepared by the BWH histology laboratory according 
to the laboratory's SOP (the protocol is not available for reference at this time). At the time of 
receipt in the cytogenetics laboratory, the 5 μm FFPE tissue samples had been mounted on 
positively charged slides with a FISH target area circled by a pathologist. The marked target area 
was etched using a diamond-tip pen so that the circled area is visible following the pretreatment. 
The slides were placed on a 56°C slide warmer for 2-hours to melt the paraffin, and then were 
placed into the ThermoBrite Elite (TBE) upside down for deparaffinization and pretreatment 
(See Appendix O). 
Hybridization Procedure (3.4) 
 Following the pretreatment step, the slides were ready for the hybridization step. The 
respective BWH cytogenetics laboratory SOP was followed for each sample type until co-
denaturation was complete (See Appendices E and L-N), at which point the standard buffer 
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slides were placed into one aluminum wrapped container and the IntelliFISH buffer slides into 
another, and both containers were placed in the FISH incubator (37°C). The standard buffer 
slides were incubated overnight as per SOP and the IntelliFISH buffer slides were incubated for 
2 hours.  
 For sample category #4 the standard buffer slides were hybridized according to the BWH 
cytogenetics laboratory SOP, which calls for unprocessed FFPE tissue samples to hybridize in 
the TBE instead of in the FISH incubators (See Appendix O). Since the TBE hybridization 
protocol performs an overnight hybridization, the TBE was not used to hybridize the IntelliFISH 
buffer slides. Following addition of the probe, the IntelliFISH slides were instead co-denatured 
on the HyBrite for 6 minutes and incubated for 2 hours at 37ºC. 
Post-Hybridization Wash (3.5) 
 After the probe hybridized to the sample DNA, either overnight for standard buffer 
samples or for 2 hours for IntelliFISH buffer samples, the slides were removed from the 
incubator. Slides were manually washed to remove unbound probe and were counterstained 
according to the BWH cytogenetics laboratory's respective SOP (See Appendices E and L-N). 
Completed slides were stored in a cold room (4°C) and exposed to as little light as possible until 
ready to be analyzed using epifluorescence microscopy. 
Comparison Method (3.6) 
When analyzing each slide, first the signals on each slide were counted to determine the 
if the sample was positive or negative for a rearrangement or abnormality. The result obtained in 
the study was compared to the clinical result that was reported back to the patient to ensure that 
our probe mixtures were yielding accurate results, because the buffer would be useless if it was 
affecting the results of the test. The BWH cytogenetics laboratory has standardized rules for 
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scoring FISH signals that were used to determine the result (See Appendix P). This experiment, 
however, focused on the quality of the signals produced by a 2-hour hybridization using 
IntelliFISH buffer compared to the quality of the signals from a standard overnight hybridization. 
A method comparison experimental approach was used to evaluate two criteria: signal intensity 
and hybridization specificity.  
Signal intensity and hybridization specificity were measured on a subjective scale from 1 
to 3. Zhao et al. (2017) describe signal intensity as ideal when the signals are bright and distinct 
so the user can easily evaluate the cells in the target area. The following criteria were used to 
measure signal intensity in this experiment: a score of 3 indicated very bright signals, 2 indicated 
normal signals, and 1 indicated weak signals that were difficult to see. Mascarello et al. (2007) 
explain that a FISH assay with perfect specificity will never produce signal over any 
chromosomal region other than the expected region on the target chromosome. The following 
criteria was used to measure hybridization specificity: a score of 3 indicated distinct signals with 
no background noise, 2 indicated very little nonspecific binding in the form of streaky signals or 
some minor background noise, and 1 indicated non-specific binding in the cell that made it 
difficult to determine signals.  
Although the method is subjective, it was designed to make specific criteria for each 
score so that one reader could score as objectively as possible across all sample types. By 
keeping the scale between 1 and 3 the reader is able to use a cell counter (as is used in routine 
FISH reading) to keep track of the number of cells given each score for both criteria. Tables 
3.6.1 and 3.6.2 contain examples of interphase and metaphase cells that would be scored as a 3, 2 
and 1 for each of the two criteria. Each cell was given a separate score for the two criteria, and an 
average score was determined for both buffers on each case. If a probe failed to hybridize and the 
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entire slide could not be read due to lack of signal, an average score of 0 was given for both 
criteria.  
Examples of Scoring Criteria on Interphase FISH 
 3                            2                               1                                
Signal 
Intensity 
 
 
 
 
Hybridization 
Specificity 
  
 
Table 3.6.1: Examples of how interphase cell signals were scored for signal intensity and hybridization specificity. Signal 
intensity score of 3 shows very bright and obvious signals. Signal intensity score of 2 shows signals that are easily visible, but not 
extremely bright. Signal intensity score of 1 has signals that are barely visible and difficult to read. Hybridization specificity 
score of 3 shows distinct signals with no background. Hybridization specificity score of 2 shows signals with background noise, 
and would also include streaky signals that are not distinct. Hybridization specificity score of 1 shows a lot of background signal 
that makes distinguishing actual signals extremely difficult, if not impossible. 
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Examples of Scoring Criteria on Metaphase FISH 
 3 2 1 
Signal 
Intensity 
 
  
Hybridization 
Specificity 
 
 
 
Table 3.6.2: Examples of how metaphase cell signals were scored for signal intensity and hybridization specificity. The 
guidelines are generally the same for interphase and metaphase cells. 
 
For the prenatal probes used in sample categories #1 and #6, rather than giving the probe 
for X, Y and 18 one score, and the probe for chromosomes 13 and 21 another, each of the five 
CEP probes were scored individually. Although commonly used together in prenatal studies, the 
CEP probes do not come premixed and are not always used together, so it would be beneficial to 
know if the IntelliFISH buffer works better with some of the CEP probes than with others. The 
other probes in the study either come premixed and/or are almost always used in conjunction 
with the other probe, so it would not have been beneficial to score them separately.  
A t-test was performed for each sample category (and each probe for categories #1 and 
#6) to determine if there were significant differences in signal intensity and hybridization 
specificity between the two buffers. The null hypothesis was that there was no difference in 
O'Connor 
23 
 
signal intensity or hybridization specificity between the standard hybridization buffer and the 
IntelliFISH hybridization buffer. The alternative hypothesis was that there is a difference in 
signal intensity or hybridization specificity between the standard hybridization buffer and the 
IntelliFISH hybridization buffer. A p value of <0.05 was considered significant.  
RESULTS AND INTERPRETATION (4) 
 The actual clinical case results (positive or negative) that were counted in this study were 
consistent with the results reported out to the patient, suggesting that FISH assays using the 
IntelliFISH buffer yield accurate results. The results in the sections below, the core of this study, 
focused on how the signal intensity and hybridization specificity produced by the IntelliFISH 
buffer compare to that of the standard buffer, and were the core of this study. 
Sample Category #1 - Direct CVS (4.1) 
 For each of the probes tested in sample category #1, there was no statistically significant 
difference in signal intensity or hybridization specificity between the IntelliFISH rapid 
hybridization buffer and the standard hybridization buffer (p > 0.05). Tables 4.1.1-4.1.5 show the 
average scores using each buffer for the five cases in category #1. The probe for chromosomes 
13 and 21 failed on one IntelliFISH buffer slide and one standard buffer slide due to a technical 
error. There were excess villi on the slide, which prevented the coverslip from lying flat and thus 
created issues with hybridization. 
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X Chromosome 
 Standard Buffer  
Signal Intensity  
Average Score  
(50 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(50 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(50 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(50 cells) 
Case #1 2.9 3 2.22 2.58 
Case #2 2.82 2.92 2.72 2.58 
Case #3 3 2.96 2.24 2.72 
Case #4 3 3 2.68 2.58 
Case #5 2.94 2.98 2.56 2.56 
Average of All Cases 2.932 2.972 2.484 2.604 
Table 4.1.1: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using a CEP probe for the X chromosome.  
 
Y Chromosome 
 Standard Buffer  
Signal Intensity  
Average Score  
(50 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(50 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(50 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(50 cells) 
Case #1 Female - No Results 
Case #2 Female - No Results 
Case #3 Turner Female - No Results 
Case #4 2.88 2.96 2.36 2.34 
Case #5 2.94 3 2.44 2.22 
Average of All Cases 
(Excluding Female 
Cases) 
2.91 2.98 2.4 2.28 
Table 4.1.2: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using a CEP probe for the Y chromosome. Cases #1-3 did not have a Y chromosome in the sample, so the cases were 
not given a score, and results were based on only cases #4 and #5. 
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Chromosome 18 
 Standard Buffer  
Signal Intensity  
Average Score  
(50 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(50 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(50 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(50 cells) 
Case #1 2.18 2.62 2.48 2.58 
Case #2 2.06 2.68 2.82 2.52 
Case #3 2.9 2.7 2.52 2.62 
Case #4 2.92 2.94 2.6 2.46 
Case #5 2.78 2.86 2.48 2.32 
Average of All Cases 2.568 2.76 2.58 2.5 
Table 4.1.3: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using a CEP probe for chromosome 18.  
 
Chromosome 13 
 Standard Buffer  
Signal Intensity  
Average Score  
(50 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(50 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(50 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(50 cells) 
Case #1 2.06 2.38 2.84 2.68 
Case #2 2.1 2.12 2.86 2.92 
Case #3 2.66 Failed - 0 2.82 Failed - 0 
Case #4 Failed - 0 2.48 Failed - 0 2.66 
Case #5 2.54 2.6 2.78 2.84 
Average of All Cases: 1.872 1.916 2.26 2.036 
Table 4.1.4: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using a CEP probe for chromosome 13.  
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Chromosome 21 
 Standard Buffer  
Signal Intensity  
Average Score  
(50 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(50 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(50 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(50 cells) 
Case #1 2.62 2.6 2.3 2.58 
Case #2 2.38 2.68 2.74 2.78 
Case #3 2.74 Failed - 0 2.68 Failed - 0 
Case #4 Failed - 0 2.86 Failed - 0 2.66 
Case #5 2.7 2.9 2.6 2.82 
Average of All Cases 2.088 2.208 2.064 2.168 
Table 4.1.5: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using a CEP probe for chromosome 21.  
  
Sample Categories #2 and #3 - Processed FFPE Tissue Samples for BCL2 and BCL6 (4.2) 
 
The samples used in both categories for cases #1-5 were considered “old” cases because 
the pre-processed slides were stored in a desiccator that failed to maintain appropriate humidity. 
The slides were thus stored in a humid environment (>50% humidity) for multiple weeks prior to 
this validation experiment, likely affecting the slide quality of the samples. Statistical data 
analyses were conducted for samples #1-10 and for #6-10 only to determine whether in fact slide 
quality affected the signal intensity and hybridization specificity scores for both categories. 
There was no significance difference between the calculated results in either category.  
For sample category #2, there was no significant difference in hybridization specificity 
for the probes diluted with the IntelliFISH rapid hybridization buffer and the probes used with 
standard hybridization buffer (p > 0.05). There was, however, a significant difference in signal 
intensity between the two buffers (p < 0.05), in that the IntelliFISH hybridization buffer had a 
significantly lower signal intensity than that of the standard buffer. Interestingly, unlike sample 
category #2, there was no significant difference in signal intensity or hybridization specificity 
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between the two buffers (p > 0.05) for sample category #3. Tables 4.2.1 and 4.2.2 show the 
average scores using each buffer for the ten cases in category #2 and the cases in category #3.   
 We cannot determine from this study why the IntelliFISH buffer seemed to perform 
worse with the BCL2 probe than the BCL6 probe, but it is unlikely that the probe alone would be 
the only factor, and likely has more to do with the actual cases and individual samples used in 
each category. Cases #5 and #9 in category #3 that were probed for BCL6, for example, failed 
when the FISH technologists in the laboratory originally probed the slide. The technologists 
reading the clinical cases had to re-hybridize the probes before the slides could be scored for 
FISH, but since no samples were re-hybridized in this experiment the cases failed for both 
buffers. If higher quality samples were available for us in this experiment, it is possible that the 
standard buffer would have performed better than the IntelliFISH buffer and the overall 
difference in signal intensity would have been significant. 
 Because of the contradicting results, I chose to run another t-test comparing the 
IntelliFISH and standard buffers on all of the pre-processed 5 µm FFPE tissue samples included 
in this study, regardless of probe (the ten cases from sample category #2 and ten cases from 
sample category #3). This test showed that for signal intensity, the IntelliFISH buffer performed 
significantly worse across the twenty pre-processed 5 µm FFPE tissue samples from sample 
categories #2 and #3 (p < 0.05). 
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BCL2 
 Standard Buffer  
Signal Intensity  
Average Score  
(50 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(50 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(50 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(50 cells) 
Case #1 Failed - 0 Failed - 0 Failed - 0 Failed - 0 
Case #2 1.96 Failed - 0 1.68 Failed - 0 
Case #3 2.24 1.86 2.14 2.76 
Case #4 2.52 1.46 2.44 2.78 
Case #5 2.28 2.48 2.7 2.82 
Case #6 2.84 2.44 2.38 2.14 
Case #7 2.86 2.3 2.62 2.8 
Case #8 2.64 Failed - 0 2.84 Failed - 0 
Case #9 2.36 1.12 2.82 2.78 
Case #10 2.54 1 2.76 2.88 
Average of All Cases 2.224 1.266 2.238 1.896 
Average of Cases #6-
10 
2.648 1.372 2.684 2.12 
Table 4.2.1: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using the BCL2 probe.  
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BCL6 
 Standard Buffer  
Signal Intensity  
Average Score  
(50 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(50 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(50 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(50 cells) 
Case #1 Failed - 0 Failed - 0 Failed - 0 Failed - 0 
Case #2 Failed - 0 Failed - 0 Failed - 0 Failed - 0 
Case #3 Failed - 0 Failed - 0 Failed - 0 Failed - 0 
Case #4 2.46 Failed - 0 2.8 Failed - 0 
Case #5 Failed - 0 Failed - 0 Failed - 0 Failed - 0 
Case #6 2.6 1.9 2.8 2.9 
Case #7 1.2 1.04 2.72 2.98 
Case #8 1.7 1.7 2.4 2.48 
Case #9 Failed - 0 Failed - 0 Failed - 0 Failed - 0 
Case #10 Failed - 0 1.4 Failed - 0  2.42 
Average of All Cases 0.796 0.604 1.072 1.078 
Average of Cases #6-
10 
1.1 1.208 1.584 2.156 
Table 4.2.2: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using the BCL6 probe.  
 
 
Sample Category #4 - Unprocessed FFPE Tissue Samples for MYC (4.3) 
 
The results of sample category #4 were similar to those of sample category #2, meaning 
there was no statistically significant difference in hybridization specificity between the 
IntelliFISH rapid hybridization buffer and the standard hybridization buffer (p > 0.05), but the 
IntelliFISH buffer performed significantly worse than the standard buffer for signal intensity (p < 
0.05). Table 4.3.1 shows the average scores using each buffer for the five cases in category #4. 
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MYC 
 Standard Buffer  
Signal Intensity  
Average Score  
(50 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(50 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(50 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(50 cells) 
Case #1 2.5 1.66 2.46 2.98 
Case #2 2.22 Failed - 0 2.98 Failed - 0 
Case #3 2.64 Failed - 0 2.96 Failed - 0 
Case #4 2.68 2.22 2.96 3 
Case #5 2.14 2.32 2.96 3 
Average of All Cases 2.436 1.24 2.864 1.796 
Table 4.3.1: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using the MYC probe.  
 
Sample Category #5 - Peripheral Blood Metaphase (4.4) 
 
For sample category #5, there was no statistically significant difference in signal intensity 
or hybridization specificity between the IntelliFISH rapid hybridization buffer and the standard 
hybridization buffer (p > 0.05). Table 4.4.1 shows the average scores using each buffer for the 
five cases in category #5. It is important to note that the category included five different probes, 
so the results give a general idea of how the buffers compare on peripheral blood metaphases, 
but do not draw conclusions about how the buffers compare for each individual probe.  
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 Standard Buffer  
Signal Intensity  
Average Score  
(5 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(5 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(5 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(5 cells) 
Case #1 HIRA/ARSA 3 2.8 2.4 2.8 
Case #2 SRY + Y 3 2.8 2 2 
Case #3 Subtel 1p 2.8 3 3 3 
Case #4 Subtel 4p 2.6 2.2 2.4 3 
Case #5 Subtel 17q 3 3 2.8 3 
Average of All Cases 2.88 2.76 2.52 2.76 
Table 4.4.1: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using various LSI probes .  
 
Sample Category #6 - Peripheral Blood Interphase (4.5) 
 
For each of the probes tested in sample category #6, there was no significant difference in 
signal intensity or hybridization specificity between the two buffers (p > 0.05). Tables 4.5.1-
4.5.5 show the average scores using each buffer for the five cases in category #6. 
X Chromosome 
 Standard Buffer  
Signal Intensity  
Average Score  
(100 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(100 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(100 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(100 cells) 
Case #1 2.97 3 2.51 2.08 
Case #2 2.97 2.99 2.52 2.87 
Case #3 2.98 3 2.46 2.06 
Case #4 2.98 3 2.22 2.3 
Case #5 3 3 2.4 2.06 
Average of All Cases 2.98 2.998 2.422 2.274 
Table 4.5.1: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using a CEP probe for the X chromosome.  
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Y Chromosome 
 Standard Buffer  
Signal Intensity  
Average Score  
(100 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(100 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(100 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(100 cells) 
Case #1 2.99 3 2.33 2.26 
Case #2 Female - No Results 
Case #3 Female - No Results 
Case #4 Female - No Results 
Case #5 2.99 3 2.17 2.27 
Average of All Cases 
(Excluding Female 
Cases) 
2.99 3 2.25 2.265 
Table 4.5.2: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using a CEP probe for the Y chromosome. Cases #2-4 did not have a Y chromosome in the sample, so the cases were 
not given a score, and results were based on only cases #1 and #5. 
 
Chromosome 18 
 Standard Buffer  
Signal Intensity  
Average Score  
(100 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(100 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(100 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(100 cells) 
Case #1 2.82 2.89 2.24 2.11 
Case #2 2.92 2.85 2.34 2.77 
Case #3 2.89 2.03 2.22 2.13 
Case #4 2.72 2.90 2.27 2.23 
Case #5 3 3 2.15 2.02 
Average of All Cases 2.87 2.734 2.244 2.252 
Table 4.5.3: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using a CEP probe for chromosome 18.  
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Chromosome 13 
 Standard Buffer  
Signal Intensity  
Average Score  
(100 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(100 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(100 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(100 cells) 
Case #1 2.20 2.97 2.9 2.55 
Case #2 2.38 2.17 2.62 2.98 
Case #3 2.46 2.77 2.57 2.62 
Case #4 2.54 2.74 2.51 2.67 
Case #5 2.76 2.83 2.47 2.59 
Average of All Cases 2.468 2.696 2.614 2.682 
Table 4.5.4: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using a CEP probe for chromosome 13.  
 
 
Chromosome 21 
 Standard Buffer  
Signal Intensity  
Average Score  
(100 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(100 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(100 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(100 cells) 
Case #1 2.17 3 2.81 1.97 
Case #2 2.54 2.22 2.35 2.91 
Case #3 2.38 2.85 2.4 2.34 
Case #4 2.17 2.86 2.37 2.57 
Case #5 2.33 2.87 2.29 2.51 
Average of All Cases 2.318 2.76 2.444 2.46 
Table 4.5.5: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using a CEP probe for chromosome 21.  
 
Sample Category #7 - Bone Marrow Metaphase (4.6) 
 
Sample category #7 showed no significant difference in signal intensity or hybridization 
specificity between the IntelliFISH rapid hybridization buffer and the standard hybridization 
buffer (p > 0.05). Table 4.6.1 shows the average scores using each buffer for the five cases in 
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category #7. Similarly to sample category #5, the results summarize how the buffers compare on 
bone marrow metaphases, but do not compare how the buffers perform for each individual probe.  
 Standard Buffer  
Signal Intensity  
Average Score  
(5 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(5 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(5 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(5 cells) 
Case #1 IGH 3 2.8 2 2.4 
Case #2 MYC 2.8 2.2 2.2 2.4 
Case #3 BCL2 3 2.8 2.8 3 
Case #4 BCL6 3 2.6 2.4 3 
Case #5 CCND1/IGH 3 3 2 3 
Average of All Cases 2.96 2.68 2.28 2.76 
Table 4.7.1: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using various LSI probes .  
 
Sample Category #8 - Bone Marrow Interphase (4.7) 
 
For sample category #8, there was no significant difference between the two buffers for 
signal intensity or hybridization specificity (p > 0.05). Table 4.7.1 shows the average scores 
using each buffer for the five cases in category #8. The results summarize how the buffers 
compare on bone marrow interphase cells, but as with sample categories #5 and #7, buffer 
performance for each individual probe used was not tested in this category.  
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 Standard Buffer  
Signal Intensity  
Average Score  
(100 cells) 
IntelliFISH Buffer  
Signal Intensity  
Average Score 
(100 cells) 
Standard Buffer 
Hybridization 
Specificity 
Average Score  
(100 cells) 
IntelliFISH Buffer 
Hybridization 
Specificity 
Average Score 
(100 cells) 
Case #1 IGH 2.63 3 2.44 2.15 
Case #2 MYC 2.8 2.14 2.69 2.99 
Case #3 CCND1/IGH 2.92 3 2.15 2.23 
Case #4 BCR/ABL1 2.8 2.95 2.16 2.25 
Case #5 PML/RARA 2.61 2.88 2.15 2.14 
Average of All Cases 2.752 2.794 2.318 2.352 
Table 4.8.1: Signal intensity and hybridization specificity average scores from the standard buffer and the IntelliFISH buffer for 
each case using various LSI probes .  
 
DISCUSSION (5) 
 
 I would conclude that the Vysis IntelliFISH Hybridization Buffer works very well on all 
sample categories and probes tested in this experiment, with the exception of the 5 µm formalin-
fixed paraffin embedded tissue samples. For direct CVS, peripheral blood and bone marrow 
samples, there was no significant difference between the IntelliFISH rapid hybridization buffer 
and the standard buffer. Although the IntelliFISH buffer did not show a significant improvement 
in signal intensity or hybridization specificity of signals, it produced results that were similar to 
the standard buffer and impressively did so in a fraction of the time. A hybridization step using 
the IntelliFISH buffer requires only two hours, in comparison to an overnight hybridization 
required when using a standard buffer, thus allowing for improvement in turnaround times for a 
FISH assay.   
 It is unclear exactly why the IntellFISH buffer did not work as well as the standard 
buffer for the 5 µm FFPE tissue samples. It is possible that the protocol used in this study (which 
was the SOP for 5 µm FFPE tissue samples in the Brigham and Women’s Hospital cytogenetics 
laboratory) was not ideal for this buffer. The manufacturer published a recommended IntelliFISH 
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buffer hybridization protocol specifically for FFPE tissue samples, so future studies using this 
protocol may produce better results. It could also be possible that two hours is just not long 
enough time for hybridization to be successful because 5 µm FFPE tissue samples are thicker 
than the other samples used in this study. Interestingly, however, the manufacturer’s published 
protocol only allows for a 2-3 hour hybridization step for FFPE tissue samples whereas other 
sample types can hybridize anywhere from 1-18 hours (with two hours being reported as 
optimal). Therefore, increasing the hybridization time for FFPE tissue samples would not 
necessarily improve the signal intensity. In the BWH cytogenetics laboratory, pre-processed 
slides are probed and hybridized at the same time (after the case is known to be positive for a 
MYC rearrangement), so even if the rapid buffer really does work well with BCL6, it still would 
not make sense to incorporate the IntelliFISH buffer into the SOP for DH B-cell lymphoma 
testing since the buffer did not perform well with BCL2. Overall, I do not think the IntelliFISH 
buffer should be used on 5 µm FFPE tissue samples, even the pre-processed samples using a 
probe for BCL6, until further testing is done to see if improvements can be made to the protocol. 
 Despite the poor performance in 5 µm FFPE tissue samples, there are numerous benefits 
to using the IntelliFISH hybridization buffer over the standard hybridization buffer for other 
sample types. As previously mentioned, the manufacturer’s protocol allows for a hybridization 
time of anywhere from 1-18 hours. Though this experiment only tested the buffer at the 
suggested optimal hybridization time of two hours, future experiments could test to see how well 
the buffer performs using different hybridization times for multiple types of samples. It would be 
interesting to see how the IntelliFISH buffer compares to the standard LSI or CEP buffers when 
used for an overnight hybridization. Although a two-hour hybridization improves turnaround 
times when samples are received early in the day, an overnight hybridization would likely still be 
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used if a sample is set up late in the day so that the slides would not have to go through a post-
hybridization wash after the lab closes. If the IntelliFISH buffer still works just as well in an 
overnight hybridization, labs could eventually stop using standard buffers altogether.  
 This research may serve as a laboratory validation to demonstrate that the IntelliFISH 
buffer works, but it is important to note that this experiment was not a blinded study. Since I 
worked on this study alone I probed and read each slide myself, so I knew while I was reading 
and scoring the slides which were hybridized using the IntelliFISH buffer and which were 
hybridized using the standard buffer. Of course, I tried to be objective based on the scoring 
criteria I created, and I do not believe that I favored one result over another, but the results would 
be more significant and more valid if the study was blinded. For future studies I would 
recommend having one individual set up, probe, and wash the slides using a coding system for 
which slides were hybridized using the IntelliFISH buffer and which were hybridized using the 
standard buffer. I would recommend having a different individual read all of the slides, and 
decoding which slides were hybridized with each buffer only after all of the slides had been read, 
thus preventing research bias that could potentially skew the results. In this study there was a 
single scorer that measured the signal intensity and hybridization specificity, which is also a 
limitation to the study. In future studies it would be beneficial to have more than one individual 
score each slide and combine the data, as is done for reading FISH slides in many clinical 
laboratories.  
 I would conclude that Abbott Molecular’s claim stating the Vysis IntelliFISH 
Hybridization Buffer makes FISH “easier, faster [and] smarter,” is true. A two-hour 
hybridization makes FISH much faster than the overnight hybridization that is currently 
performed in most clinical laboratories, and it is smarter to include guanidine thiocyanate and 
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reduce formamide levels in the hybridization buffer to increase the speed of the hybridization 
reaction. The actual process of setting up and reading FISH slides is similar regardless of which 
buffer is used, so it is not necessarily easier, but I do think that laboratory efficiency and 
workflow becomes optimized. This research was sufficient for validation of the Vysis 
IntelliFISH Hybridization Buffer. Since the conclusion of the study, the BWH cytogenetics 
laboratory has started to edit the SOPs for CVS, peripheral blood and bone marrow FISH studies 
to include a rapid hybridization. Implementation of the new protocols into routine FISH assays 
will improve turnaround times without compromising the quality of the results, thus increasing 
laboratory efficiency and more importantly, patient care and satisfaction.  
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APPENDIX A 
 
MATERIAL SAFETY DATA SHEET 
HYBRIDIZATION BUFFER - #30-670003 
 
1.0 CHEMICAL PRODUCT AND COMPANY IDENTIFICATION 
PRODUCT NAME:  
• CEP Hybridization Buffer 
• LSI Hybridization Buffer 
• WCP Hybridization Buffer 
• CGH Hybridization Buffer 
 
MANUFACTURERJSUPPLIER: EMERGENCY INFORMATION: 
Vysis, Inc. 1 (800) 424-9300 CHEMTREC(USA) 
3100 Woodcreek Drive 
Downers Grove, IL 60515 U.S.A. 
1 (703) 527-3887 CHEMTREC (INTERNATIONAL) 
(630) 271-7000 
 
2.0 COMPOSITION/INFORMATION ON INGREDIENTS 
Component CAS # Range % by Wt. 
Formamide 75-12-7 60-100 
Sodium Chloride 7647-14-5 0-5 
Sodium Dextran Sulfate 9011-18-1 10-15 
Water 7732-18-5 7-13 
(See Section 8.0, "Exposure Controls/PersonaI Protection", for exposure guidelines) 
 
3.0 HAZARDS IDENTIFICATION 
EMERGENCY OVERVIEW: Warning! Causes eye, skin and respiratory irritation. Causes gastrointestinal irritation. 
Reproductive hazard based on studies with laboratory animals. Can cause liver damage. Can cause kidney damage. 
POTENTIAL HEALTH EFFECTS: 
EYE CONTACT: Causes eye irritation. See "Toxicological Information" section (section 11.0). 
SKIN CONTACT: Reproductive hazard based on studies with laboratory animals. Can cause liver damage. Can cause 
kidney damage. See "Toxi@logical Information" section (Section 11.0), 
INHALATION: Inhalation causes headaches, dizziness, drowsiness, nausea, and respiratory irritation. Can cause liver 
damage if inhaled. Can cause kidney damage if inhaled. See "Toxicological Information" section (Section 11.0). 
INGESTION: Reproductive hazard based on studies with laboratory animals. Ingestion may cause nausea, vomiting, 
gastrointestinal irritation, and central nervous system effects. Can cause liver damage if swallowed. Can cause 
kidney damage if swallowed. See "Toxicological Information" section (Section 11.0). 
HMIS CODE: (Health:2) (Flammability:O) (Reactivity:O) 
NFPA CODE: (Health•2) (Flammability:O) (Reactivity:O) 
 
4.0 FIRST AID MEASURES 
EYE: Flush eyes with plenty of water. Get medical attention if irritation persists.  
SKIN: Wash exposed skin with soap and water. Remove contaminated clothing and thoroughly dean and dry before reuse. Get 
medical attention if irritation develops. 
INHALATION: If adverse effects occur, remove to uncontaminated area. Give artificial respiration if not breathing. Get 
immediate medical attention, 
INGESTION: If swallowed, drink plenty of water, do induce vomiting. Get immediate medical attention. 
5.0 FIRE FIGHTING MEASURES 
FLASHPOINT: Greater than 2000 F (930C) 
UEL: Not determined. 
LEL: Not determined. 
AUTOIGNITION TEMPERATURE: Not determined. 
FLAMMABILITY CLASSIFICATION: Combustible Liquid 
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EXTINGUISHING MEDIA: Agents approved for Class B hazards (e.g., dry chemical, carbon dioxide, foam, steam) or water 
fog. UNUSUAL FIRE AND EXPLOSION HAZARDS: None identified. 
FIRE-FIGHTING EQUIPMENT: Firefighters should wear full bunker gear, including a positive pressure self-contained 
breathing apparatus. 
HAZARDOUS COMBUSTION PRODUCTS: Incomplete burning can produce carbon monoxide and/or carbon dioxide and 
Other harmful products. 
 
6.0 ACCIDENTAL RELEASE MEASURES 
Remove mechanically or contain on an absorbent material such as dry sand or earth. use appropriate protective equipment. 
 
7.0 HANDLING AND STORAGE 
HANDLING: Use with adequate 
ventilation. STORAGE: No special 
requirements 
8.0 EXPOSURE CONTROLS 1 PERSONAL PROTECTION 
EYE: Do not get in eyes. Wear safety glasses/goggles. 
SKIN: Do not get on skin or Clothing. Wear protective clothing and gloves. 
INHALATION: Use with adequate ventilation. If ventilation is inadequate, use NIOSH/MSHA certified respirator that will 
protect against organic vapor and dust/mist, 
ENGINEERING CONTROLS: Control airborne concentrations below the exposure guidelines. 
EXPOSURE GUIDELINES: 
Component  CAS # Exposure Limits 
Formamide  75-12-7 OSHA PEL: 20ppm(1989) 
OSHA STEL: 30ppm(1989) 
ACGIH TLV-TWA: IOppm(skin) 
Sodium Chloride  7647-14-5 No exposure limit established. 
Sodium Dextran Sulfate  9011-18-1 No exposure limit established. 
Water  7732-18-5 No exposure limit established.  
9.0 CHEMICAL AND PHYSICAL PROPERTIES 
APPEARANCE AND ODOR: Clear. Odorless. Liquid. 
pH: Not determined. 
VAPOR PRESSURE. Not determined 
VAPOR DENSITY: Not determined 
BOILING POINT  950F(350C) 
MELTING POINT: Not determined 
SOLUBILITY IN WATER: Totally soluble 
SPECIFIC GRAVITY (Water  1) I . I (estimated) 
 
10.0 STABILITY AND REACTIVITY 
STABILITY: Stable. 
CONDITIONS TO AVOID: None identified. 
MATERIALS TO AVOID: None identified. 
HAZARDOUS DECOMPOSITION: Incomplete burning can produce carbon monoxide and/or carbon dioxide and other 
harmful products. 
HAZARDOUS POLYMERIZATION: Will not occur. 
11.0 TOXICOLOGICAL INFORMATION 
ACUTE TOXICITY DATA: 
EYE IRRITATION: Testing not conducted. See Other Toxicity Data. 
SKIN IRRITATION: Testing not conducted. See Other Toxicity Data. 
DERMAL LD50: Testing not conducted. See Other Toxicity Data. 
ORAL LD50: Testing not conducted. See Other Toxicity Data. 
INHALATION LC50: Testing not conducted. See Other Toxicity Data. 
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OTHER TOXICITY DATA: 
Specific toxicity tests have not been conducted on this product. Our hazard evaluation is based on information from similar 
products, the ingredients, technical literature, and/or professional experience. 
Acute toxicity of formamide in a variety of animal species is relatively low (the oral LD50 in rats is 6000 mg/kg, the dermal 
LD50 in rabbits is 6000 mg/kg, and the inhalation LC50 in rats is >3900ppm). Formamide is expected to cause eye, skin, 
respiratory, and gastrointestinal irritation. Inhalation or ingestion Of formamide may cause headaches, dizziness, drowsiness, 
and nausea. Prolonged or repeated skin contact to high concentrations of formamide may cause liver or kidney toxicity. 
Formamide is embryotoxic and weakly teratogenic in rabbits at concentrations that were not maternally toxic. 
12.0 ECOLOGICAL 
INFORMATION Ecological testing has not been conducted on this product. 
 
13.0 DISPOSAL INFORMATION 
Disposal must be in accordance with applicable federal, state, or local regulations. Since the emptied containers retain 
product residue, follow label warnings even after container is emptied. 
14.0 TRANSPORTATION INFORMATION 
U.S. DEPT. OF TRANSPORTATION 
 Shipping Name Not Regulated 
INTERNATIONAL INFORMATION: 
 Sea (IMO/IMDG) Not Regulated 
 Air (ICAO/IATA) Not Regulated 
 European Road/Rail (ADA/RID) Not Regulated 
 CanadianTransportation of Dangerous Goods Not Regulated 
 
15.0 REGULATORY INFORMATION 
CERCLA SECTIONS 102A/103 HAZARDOUS SUBSTANCES (40 CFR PART 302.4): This product is not reportable under 
CFR 302.4 SARA TITLE Ill SECTION 302 EXTREMELY HAZARDOUS SUBSTANCES (40 CFR PART 355): This product 
is not regulated under Section 302 of SARA and 40 CFR Part 355. 
SARA TITLE Ill SECTIONS 3111312 HAZARDOUS CATEGORIZATION (40 CFR PART 370): This product is not regulated 
under SARA Title Ill Section 311/312. 
SARA TITLE Ill SECTION 313 (40 CFR PART 372): This product is not regulated under Section 313 of SARA and 40 CFR 
Part 372. 
U.S. INVENTORY (TSCA): Listed on inventory. 
OSHA HAZARD COMMUNICATION STANDARD: Irritant, Teratogenic, CNS Effects. Target organ effects. 
 
16.0 OTHER INFORMATION 
By: 
Mary L. Prisby 
Environmental Health and Safety Coordinator 
This Material Safety Data Sheet conforms to the requirements of ANSI ZOO. 1. 
This Material Safety Data Sheet and the information it contains is offered to you in good faith as accurate. We have reviewed 
any information contained in this data sheet which we received from sources outside our company. We believe that information 
to be correct but cannot guarantee its accuracy or completeness. Health and safety precautions in this data sheet may not be 
adequate for all individuals and/or situations. It is the user's obligation to evaluate and use this product safely and to comply with 
all applicable laws and regulations. No statement made in this data sheet shall be construed as a permission or recommendation 
for the use of any product in a manner that might infringe existing patents. No warranty is made, either express or implied 
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APPENDIX B 
    
 
Release Date: 7/20/16 
 Product Name   
08N87-001       VYSIS IntelliFISH Hybridization Buffer 
Components:  
30-804906        VYSIS IntelliFISH Hybridization Buffer 
Abbott Customers: 
For additional information, please contact your Abbott Customer Support Center Representative by calling 1-800-527-1869, 1-
800-323-9100, or 1-800-235-5396. 
Abbott employees: 
For additional information relative to the content of the MSDSs, please contact your local Safety Representative. 
 
1 Identification 
• Product name: VYSIS IntelliFISH Hybridization Buffer 
• ADD List number: 30-804906 
• Application of the substance / mixture: For In Vitro Diagnostic Use 
• Manufacturer / Supplier: Abbott Molecular 1300 E. Touhy Ave Des Plaines, IL 60018-3315  USA Tel. Abbott Molecular Customer Service: 1-800-553-7042 
• Department issuing SDS: Abbott Diagnostics Environmental Health and Safety 
• Emergency telephone number: Contact the CHEMTREC® Emergency Call Center for assistance with transportation or hazardous materials emergencies (24 hours/day, 7 days/week).  Refer to Abbott customer number 675834. 
- Telephone (800) 424-9300 (toll-free) if you are calling from within the United States, Canada, Puerto Rico and theVirgin Islands. 
- Telephone +1 (703) 527-3887, the international and maritime number (collect calls accepted), if you are callingfrom outside the United States or from a ship at sea. 
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2 Hazard(s) identification 
• Classification of the substance or mixture Repr. 1B H360 May damage fertility or the unborn child. 
• Label elements 
• GHS label elements: The product is labelled according to the Globally Harmonized System (GHS). 
• Hazard pictograms:  
• Signal word: Danger 
• Hazard-determining components of labeling: Formamide 
• Hazard statements: H360 May damage fertility or the unborn child. 
• Precautionary statements: 
 P201 Obtain special instructions before use. 
 P280 Wear protective gloves/protective clothing/eye protection. P202 Do not handle until all safety precautions have been read and understood. P308+P313 IF exposed or concerned: Get medical advice/attention. 
 P405 Store locked up. 
 P501 Dispose of contents / container in accordance with local regulations. 
• Routes of Exposure: Eye Inhalation Skin 
3 Composition/information on ingredients • Chemical characterization: Mixture of chemical and/or biological substances for in vitro diagnostic use. • Hazardous chemical ingredients per U.S. OSHA criteria (29 CFR 1910.1200 Hazard 
Communication): CAS: 75-12-7 Formamide 34.20% CAS: 593-84-0 Guanidine thiocyanate 12.30% 
 
• Hazard Overview • Health: May cause irreversible eye damage. Contains a suspected reproductive toxin. May cause harm to the unborn child. 
• Fire: Noncombustible 
• Reactivity: Minimal hazard - Stable, even in a fire.  Not reactive with water.  Not an oxidizer. 
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5 Fire-fighting measures 
• Suitable extinguishing agents Dry chemical, carbon dioxide (CO2), water spray or regular foam. 
- Caution: CO2 will displace air in confined spaces and may cause an oxygen-deficient atmosphere. 
- For larger fires: There are no unique chemical or reactivity hazards that would impact firefighting decisions relatedto this product.  Use firefighting measures that suit the environment. 
• Special hazards arising from the substance or mixture There are no unique chemical or reactivity hazards that would impact firefighting decisions due to the chemicals in this product. 
• Protective equipment For large fires, wear appropriate heat- and flame-resistant personal protective equipment and a NFPA/NIOSH approved positive-pressure, self-contained breathing apparatus. 
4 First-aid measures 
• After inhalation: Remove from source of exposure. If irritation or signs of toxicity occur, seek medical attention. 
• After skin contact: Take off any clothing that the product touched. Rinse skin with running water for 15 to 20 minutes.  Seek medical attention if irritation or signs of toxicity occur. 
• After eye contact: Rinse open eye(s) cautiously with water for several minutes.  Remove contact lenses, if present and easy to do. Continue rinsing.   Seek medical attention and appropriate follow-up.  Wash hands after handling. Symptoms (such as pain) may be delayed and lead to underestimating the possible damage.  Provide medical observation for at least 48 hours after exposure. 
• After swallowing: Rinse mouth with water. If irritation or signs of toxicity occur, seek medical attention. • Information for Medical Personnel 
• Most important symptoms and effects, both acute and delayed: Liver effects Kidney effects Headache Disorientation Irreversible eye damage Dizziness 
• Medical conditions aggravated by exposure: Pre-existing cardiovascular ailments Pregnancy Pre-existing eye ailments Pre-existing liver condition Pre-existing kidney ailments Pre-existing nervous system ailments 
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6 Accidental release measures 
• Personal precautions, protective equipment and emergency procedures Minimize exposure by using appropriate personal protective equipment as listed in Section 8.  Stop leak if possible. Keep unprotected persons away. 
• Environmental precautions Prevent liquid and vapor from entering sewage system, storm drains, surface waters, and soil. 
• Methods and material for containment and cleaning up Blot up small volumes of spilled or spattered product with paper towels or similar materials. 
- Contain larger spills by placing absorbants around the outside edges of the spill. Absorb with any material suitablefor water-based liquids - e.g. paper towels, universal sorbents, sand, diatomite, sawdust, etc. Clean the affected area.  Suitable cleaners are: 
- warm water and detergent or similar cleansing agent Dispose of spilled and contaminated material in accordance with Federal, State, and Local regulations.  See Section 13 for information that may impact disposal of materials contaminated with this product. 
• Reference to other sections See Section 7 for information on safe handling. See Section 8 for information on personal protection equipment. See Section 13 for disposal information. 
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USA  
• Information about storage in one common storage facility: Store in original packaging. 
• Further information about storage conditions: Protect from heat and direct sunlight. 
7 Handling and storage 
• Precautions for safe handling: Prevent formation of aerosols or vapors. Avoid contact with eyes. 
• Information about protection against explosions and fires: No special measures required. 
• Requirements to be met by storerooms and receptacles: Store only in the original container. Refer to the package insert or product label for additional information on storage conditions for product quality. 
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• Body protection: 
Normal use: protect personal clothing from spatters and small spills.  Wear a laboratory 
coat (or other protective clothing required by your institution). 
Larger spills (e.g. that can saturate cloth): wear appropriate water-repellant covering 
over clothing. 
8 Exposure controls/personal protection 
• Components with Occupational Exposure Limits The following constituent is the only constituent of the product which has a PEL, TLV or other recommended exposure limit. At this time, the remaining constituent has no known exposure limits. 
CAS: 75-12-7 Formamide (34.20 %) REL TWA: 15 mg/m³, 10 ppm Skin TLV TWA: 18 mg/m³, 10 ppm Skin 
• General protective and hygienic measures: Always maintain good housekeeping and follow general precautionary measures. Do not eat, drink or store food and beverages in areas where chemicals or specimens are used. Wash hands before breaks, after handling reagents and specimens, and at the end of the workshift. Immediately remove all soiled and contaminated clothing. Store protective clothing separately. 
• Breathing equipment: Normal use and storage of product - respiratory protection is not necessary if room is well ventilated. Small-volume spills (e.g. small enough to clean up with a paper towel or small sorbent pad) - respiratory protection should not be necessary if room is well ventilated. Other unusual conditions (e.g. volume spilled too big to clean up with materials in arm's reach) - Use appropriate NIOSH-approved air-purifying respirator if airborne chemical concentrations may exceed the exposure limit (if any) listed above. Hazardous Materials Emergencies or Firefighting - use NIOSH/NFPA-approved respiratory protection. 
• Hand protection: Wear impervious gloves if hand contact with the material is anticipated. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. 
• Material of gloves and breakthrough time of the glove material: The glove material must be suitable for use in a microbiological laboratory and have a measured breakthrough time of at least 30 minutes, such as those with a Class 2 protection index per EN374 (or equivalent standard applicable in your region). NOTE: This recommendation applies only to the product stated in this Safety Data Sheet.  When dissolving in or mixing with other substances, contact the supplier of approved gloves. 
• Eye protection: Wear safety glasses or other protective eyewear. If splash potential exists, wear full face shield or goggles. 
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9 Physical and chemical properties 
• General Information 
• Form: Liquid 
• Color: Colorless 
 • Odor: Odorless 
• pH-value at 20 °C (68 °F) 7.5 
• Melting point/Melting range: Not determined 
• Boiling point/Boiling range: Not determined 
• Flash point Not applicable 
• Flammability (solid, gaseous) Not applicable 
• Auto igniting Product is not self-igniting. 
• Danger of explosion Product does not present an explosion hazard. 
• Explosion limits 
• Lower: Not determined 
• Upper: Not determined 
• Density Not determined 
• Evaporation rate: Not determined 
• Solubility in / Miscibility with 
• Water: Fully miscible 
• Dynamic: Not determined 
 • Water: 23.7 % 
 
10 Stability and reactivity 
• Thermal decomposition / conditions to be avoided No decomposition if used and stored according to specifications. 
• Possibility of hazardous reactions: Reacts with strong acids and oxidizing agents. 
• Conditions to avoid: No further relevant information available. 
• Incompatible materials: No further relevant information available. 
• Hazardous decomposition products: No dangerous decomposition products known. 
 USA  
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11 Toxicological information 
• Acute toxicity 
• LD50/LC50 values for hazardous ingredients per OSHA criteria: • Ingredients (100% pure substance/s): 
CAS: 75-12-7 Formamide Oral LD50 3150 mg/kg (mouse)  5577 mg/kg (rat)  Mutagenicity Negative (Ames Assay)  Target Organ Effects  (other) Formamide is highly embryotoxic and teratogenic in animals receiving oral, interperitoneal and dermal dosages that did not cause maternal toxicity (LOAEL= 0.19 ml/kg).  Formamide also caused testicular atrophy at near lethal dosages. 
CAS: 593-84-0 Guanidine thiocyanate Oral LD50 475 mg/kg (rat) By analogy to Guanidine hydrochloride. Dermal LD50 >2000 mg/kg (rabbit) By analogy to Guanidine hydrochloride.  LD50 (ip) 300 mg/kg (mouse) By analogy to Guanidine hydrochloride.  Target Organ Effects  (other) By analogy to Guanidine hydrochloride.  Produced severe skin irritation in rabbits and mild to moderate eye irritation in animals.  Thiocyanate dust may cause irritation of the mucous membranes and upper respiratory tract.  Low doses of thiocyanates may cause headache, drowsiness, dizziness, narcosis, hypotension, visual hallucinations, confusion and cyanosis.  Large doses may lead to psychotic episodes. 
• Primary toxicological effects of the final product: 
• Skin irritation: No irritant effect. 
• Eye irritation: Strong irritant, with the danger of severe eye injury. 
• Sensitization: No sensitizing effects known. 
• Additional toxicological information: Product is suspected to cause birth defects. • Carcinogenic categories • IARC (International Agency for Research on Cancer) None of the ingredients is listed. • NTP (National Toxicology Program) None of the ingredients is listed. • OSHA-Ca (Occupational Safety & Health Administration) None of the ingredients is listed. 
• Target organs/systems: Eye Liver Kidneys 
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Cardiovascular system Reproductive system 
12 Ecological information 
• Aquatic toxicity: No further relevant information available. 
• Additional ecological information 
• General notes: Do not allow undiluted product or large quantities of it to reach ground water, water course, or sewage system. 
• Results of PBT and vPvB assessment 
• PBT: Not applicable 
• vPvB: Not applicable 
13 Disposal considerations 
• Recommendation for disposal of unused product: Dispose in accordance with federal, state and local regulations. 
• Recommendation for disposal of packaging: Non-contaminated packaging may be used for recycling. Refer to applicable local regulations and institutional policies. For disposal of contaminated packaging, refer to applicable local regulations and institutional policies. 
• Recommended cleansing agent: Water with cleansing agents, if necessary. 
Nervous system 
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USA   
 IATA 
 Remarks: Not restricted for transportation. 
 
 
14 Transport information 
 • DOT, ADN, IMDG, IATA none • UN proper shipping name • DOT, ADR, ADN, 
IMDG, IATA none 
• Transport hazard class(es) 
• DOT, ADR, ADN, IMDG, IATA 
• Class none 
• DOT, IMDG, IATA none • Environmental hazards • Marine pollutant: No • Additional information 
• DOT 
• Remarks: Not restricted for transportation. 
• ADR 
• Remarks: Not restricted for transportation. 
• IMDG 
• Remarks: Not restricted for transportation. 
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16 Other information The information and recommendations contained herein are based upon information or tests believed to be reliable. Abbott Laboratories does not guarantee the accuracy or completeness of this information or recommendations contained herein, NOR SHALL ANY OF THIS INFORMATION CONSTITUTE A WARRANTY, WHETHER EXPRESSED OR IMPLIED, AS TO THE SAFETY OF THE GOODS, THE MERCHANTABILITY OF THE GOODS, OR THE FITNESS OF THE GOODS FOR A PARTICULAR PURPOSE. 
 USA  
15 Regulatory information 
• SARA (Superfund Amendments and Reauthorization Act of 1986 - USA): •    Section 302/304 (40CFR355.30 / 40CFR355.40):    The product does not contain listed substances. •    Section 313 (40CFR372.65):    The product does not contain listed substances. 
• California Proposition 65 (USA): •    Chemicals known to cause cancer:    The product does not contain listed substances. •    Chemicals known to cause female reproductive toxicity: None of the ingredients is listed. •    Chemicals known to cause male reproductive toxicity: None of the ingredients is listed. •    Chemicals known to cause developmental reproductive toxicity: None of the ingredients is listed. 
• Labelling according to Directives 67/548/EEC or 1999/45/EC 
• Hazard designation of product: Toxic 
• Hazard determining substance/s of labeling: Formamide Guanidine thiocyanate 
• Risk phrases: 61 May cause harm to the unborn child 32 Contact with acids liberates very toxic gas. 41 Risk of serious damage to eyes. •    Safety phrases: 53 Avoid exposure - obtain special instructions before use. 45 In case of accident or if you feel unwell, seek medical advice immediately. 
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This information is not a substitute for the advice of a health care professional, nor is it a recommendation for any particular course of treatment.  It is not intended to supplement, modify or supersede any information (e.g. labeling and package inserts) provided with respect to the medical use of the product. Abbott Laboratories assumes no responsibility for results obtained or for incidental or consequential damages, including lost profits, arising from the use of these data.  No warranty against infringement of any patent, copyright or trademark is made or implied. 
• Department issuing SDS                        - Abbott Diagnostics Safety, Health and Environmental Assurance                          Department 0571 
• Contact Tel. Abbott Molecular Customer Service: 1-800-553-7042  - General information about this product:                          Abbott Diagnostics                          Technical Support                          100 Abbott Park Road                          Abbott Park, IL 60064-3500                           Phone:  1-877-4 ABBOTT 
• Date of preparation / last revision 07/20/2016 / 1 
• Abbreviations and acronyms: ADR: Accord européen sur le transport des marchandises dangereuses par Route (European Agreement concerning the International Carriage of Dangerous Goods by Road) IMDG: International Maritime Code for Dangerous Goods DOT: US Department of Transportation IATA: International Air Transport Association EINECS: European Inventory of Existing Commercial Chemical Substances ELINCS: European List of Notified Chemical Substances CAS: Chemical Abstracts Service (Division of the American Chemical Society) LC50: Lethal concentration, 50 percent LD50: Lethal dose, 50 percent PBT: persistent, bioaccumulative and toxic vPvB: very persistent and very bioaccumulative OSHA: Occupational Safety & Health TLV: Threshold Limit Value PEL: Permissible Exposure Limit REL: Recommended Exposure Limit Repr. 1B: Reproductive toxicity  Category 1B • * Sections marked with an asterisk (*) have been altered since the previous version.   
 
 
 
 
 USA  
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APPENDIX C 
Chromosome/Region/
Gene 
Cytogenetic Location Probe Name Fluorophore Abbott Molecular 
Catalog Number 
X Xp11.1-q11.1 Alpha 
Satellite DNA 
Vysis CEP X (DXZ1) Spectrum Orange 05J08-033 
Y Yq12 Satellite III 
DNA 
Vysis CEP Y (DYZ1) Spectrum Green 05J10-034 
18 18p11.1- q11.1 Alpha 
Satellite DNA 
Vysis CEP 18 
(D18Z1) 
Spectrum Aqua 05J09-028 
13 13q14.2 Vysis LSI 13 (13q14) Spectrum Green 05J14-028 
21 21q22.13- q22.2 Vysis LSI 21 Spectrum Orange 05J13-012 
5’ BCL2 18q21.3 Vysis LSI BCL2 
(Break Apart) 
Spectrum Green 07J75-001 
3’ BCL2 Spectrum Orange 
3’ BCL6 3q27 Vysis LSI BCL6 
(Break Apart) 
Spectrum Green 01N23-020 
5’ BCL6 Spectrum Orange 
5’ MYC 8q24.21 Vysis LSI MYC 
(Break Apart) 
Spectrum Green 05J91-001 
3’ MYC Spectrum Orange 
HIRA 22q11.2 Vysis LSI TUPLE1 Spectrum Orange 05J21-028 
ARSA 22q13.3 Vysis LSI ARSA Spectrum Green 
SRY  Yp11.3 Vysis LSI SRY Spectrum Orange 05J27-007 
X Xp11.1-q11.1 Alpha 
Satellite DNA 
Vysis CEP X (DXZ1) Spectrum Green 
Y Yq12 Satellite III 
DNA 
Vysis CEP Y (DYZ1) Spectrum Aqua 05J09-034 
Subtelomere 1p CEB108/T7 TelVysion 1p Spectrum Green 05J03-091 
Subtelomere 4p GS10K2/T7 
(D4S3359) 
TelVysion 4p Spectrum Green 05J03-014 
Subtelomere 17q D17S928 TelVysion 17q Spectrum Orange 05J04-027 
5’ IGH 14q32.3 Vysis LSI IGH (Break 
Apart) 
Spectrum Orange 05J73-001 
3’ IGH Spectrum Green 
CCND1 11q13.3 Vysis LSI CCND1 
(DCDF) 
Spectrum Orange 05J69-001 
IGH 14q32.3 Vysis LSI IGH 
(DCDF) 
Spectrum Green 
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BCR 9q34.1 Vysis LSI ABL1-ASS1 
(DCDF) 
Spectrum Orange 05J82-001 
ABL1 22q11.2 Vysis LSI BCR 
(DCDF) 
Spectrum Green 
PML 15q24 Vysis LSI PML 
(DCDF) 
Spectrum Orange 05J70-001 
RARA 17q21.1-q21.2 Vysis LSI RARA 
(DCDF) 
Spectrum Green 
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APPENDIX D 
CVS: DIRECT HARVESTING 
 
1.  Incubate an equivalent of 4 “nice” branched pieces of villi in a P-35 dish with 2.5 mL 
hypotonic solution for 30 minutes. 
 
2.  Remove dish from incubator.  Gently add ½ Pasteur pipette of fresh 3:1 methanol: 
acetic acid to the hypo in the dish.  Let stand for 5 minutes. 
 
3.  Carefully aspirate fixative/hypotonic mixture from around the villi without removing 
any villi.  Add one pipette full of 3:1 fixative.  Let stand for 15 minutes.  Aspirate 
fixative.  Repeat this procedure two times for 10 minutes each time. 
 
4.  Carefully aspirate last fixative from around the villi without removing any 
villi.  Leave villi clumped together at one edge of the P-35 dish and place the dish on 
an angle on its cover.  Add 10 drops of 60 % acetic acid solution for FISH X, Y, 21 or 
add 15 drops of 60% acetic acid solution for FISH ALL.  Let stand 10 minutes or 
until villi become “ghosts”. 
 
5.  For FISH X, Y, 21 mark 3 glass slides with etched rings (Gold Seal # 3032) and for 
FISH ALL mark 4 glass slides with etched rings (NOTE: for the final slide for both 
FISH procedures use the right well of the 2 wells).  FISH X, Y, 21 will use 5 wells 
and FISH ALL will use 7 wells. 
 
6.  Triturate villi/acetic acid mixture several times to break up villi.  Fill each well with 
two drops of suspension.  Place slides on slide warmer until dry. 
 
7.  Place slides on a tray and give them to the FISH technologist for processing (for 
FISH procedures refer to the FISH procedure manual). 
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APPENDIX E 
DOUBLE HIT LYMPHOMA PROTOCOL IN 5 MICRON SECTIONS 
 
Principle:  Double-hit lymphomas are a unique subset of lymphomas characterized by a 
MYC rearrangement in conjunction with a BCL2 and/or a BCL6 rearrangement. Patients 
with double-hit lymphomas often have a poor prognosis so when diffuse large B-cell or 
related lymphomas are suspected of being double-hit lymphomas they should be tested 
for MYC and BCL2 or BCL6 rearrangements. 
 
Clinical Significance:  Slides submitted for testing sometimes are suboptimal due to: 
limited sample size, high cellularity with overlapping cells, crush artifact or necrosis. 
Accurate reading of dual color dual fusion FISH probes can be challenging in this 
context. A protocol utilizing break-apart probes has been developed. 
 
Specimen:  5 micron unstained slides 
 
Procedure: 
 
1.  Select the three best unstained slides (complete, well-preserved tissue) and match each 
 to the marked H&E slide. 
  
2.  Circle the indicated target tumor area on each unstained slide using a diamond pen. 
 
3.  Bake all three unstained slides on the Thermobrite at 56oC overnight. 
 
4.  Process both slides in the TBE using the "B&W Tissue Pretreatment" protocol. 
 
5.  Upon completion of the program, hybridize one slide with MYC probe overnight in 
 the TBE using the "B&W Tissue Hybe" program.  Store the other two slides in 
the  desiccator until needed. 
 
6.  Wash the MYC slide in the TBE using the "B&W Post Treatment" protocol.  
 
7.  Evaluate, score and capture the MYC slide according to standard scoring procedures, 
 previously described in the FISH SOPM.  
 
8.  If the MYC slide is positive for MYC rearrangement, hybridize one slide with BCL2 
and  
 the other slide with BCL6.   
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9.  Dehydrate slides that were previously stored in the dessicator in 70%, 80%, 90%, and 
 100% ethanol for 2 minutes in each jar at 20 to 25°C.  Air dry. 
 
10.  Pre-warm the BCL2 and BCL6 probes by placing the vial(s) in the top drawer on the  
FISH bench for a minimum of  5 minutes.  Vortex the vial(s) for 5 seconds and then 
touch spin the vial(s)in a balanced microcentrifuge.   
 
11.  Record the lot number and expiration date of the probe and the set up technologist's 
in the appropriate field on the score sheet (Appendix ). 
 
12.  Using a P20, apply an appropriate amount of probe to the center of the marked area 
and place a coverslip large enough to cover the marked area on top of the probe.   
Coverslips: 12 mm circle, 18x18 mm square, 22x22 mm square, 22x30 mm rectangle 
 
13.  Allow probe to spread evenly and gently press out any air bubbles with a wooden  
applicator.  Seal coverslip with rubber cement. 
 
14.  Co-denature the probes and slides for 6 minutes on the Hybrite at 80°C. 
  
15.  Incubate overnight at 37oC in a humidified chamber.  
 
16.  Remove rubber cement from slide using forceps and discard the cover slip. Place 
slide in a coplin jar containing 0.4X SSC/0.3% Tween 20 (pH 7.0).  Incubate at 73o C  for 
2 minutes.  
 Do not process more than 8 slides at one time.  
 Place coplin jar in 73o C water bath ~15 minutes before starting step 16. 
 
17.  Transfer slide to a coplin jar containing 2X SSC/0.1% Tween 20 (pH 7.0) and 
incubate at 20 to 25°C for 1 minute. 
 
18.  Transfer slides to 1X PBD at 20 to 25°C and hold there until ready to cover slip. 
 
19.  Apply 15 uL DAPI II/Antifade to the slide and place a 24x50 mm #1 coverslip on the 
slide. 
 
20.  Evaluate, score and capture the BCL2 and the BCL6 slides according to standard 
scoring procedures.  Print a representative FLEX image for both probes, normal and   
abnormal. 
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APPENDIX F 
 
SET-UP & CULTURE OF ROUTINE PERIPHERAL BLOOD SAMPLES 
 
Peripheral blood samples should be collected in a sodium heparin tube (green top) and 
kept at room temperature. 
Collection specifications: 
 
For chromosome and FISH analysis:  
5-10 mL for adult and 1-2 mL are required if the patient is an infant (less than one year of 
age). 
For FISH on interphase nuclei, an additional 0.3 mL of blood is needed for an infant. 
 
For microarray, a minimum of 0.5 mL of blood should be drawn in a sodium heparin 
tube.   
NOTE:  Sample may be accepted for array if drawn in EDTA.   
 
It is best to have bloods drawn and received for culture set-up on Monday, Tuesday, 
Wednesday, Friday or Saturday.  Bloods received on Thursday are set up on Friday 
morning, thus maintaining the optimal 72 hr culture time (except for STAT cases which 
will be cultured for 48 hours and harvested on Saturday).   
Each sample is assigned a CG number at accessioning. Each sample tube is labeled with 
the proper CG number. 
 
Using universal precautions: 
All cultures are set up in a laminar flow hood in numerical order with only one sample 
at a time in the hood. 
1. For all routine and FISH samples, set up four 15 mL centrifuge tubes 
(Falcon#352099). Label each tube with CG report labels and write the tube number 
on each (#1 - #4) and place 2 inch wide Scotch tape over each label. 
 
2. To tubes 1 and 2, add 5 mL of Medium A 
 
3. To tubes 3 and 4, add 5 mL of Medium B 
  
4.  To each tube add 0.4 mL whole blood for adults or 0.3 mL whole blood for infants.  
Triturate           3 times with pipet to mix well, loosely cap culture tubes and place in a 
slanted culture rack (Fisher 20mm/40places #14796-5). 
 
5.  Incubate cultures at 37˚C in an atmosphere of 5% CO2 and 95% humidity. Tubes 
should be kept at a 20° angle to maintain an increased growth surface.  Routine 
cultures are harvested after 72 hours of incubation and STAT "A" cultures are 
harvested after 48 hours. 
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6.  Write case number on harvest list located on each incubator door to correspond with 
harvest day and indicate "STAT” when appropriate. 
 
PLEASE NOTE:  
 
Specimens for microarray should be left in the designated container on the isolation 
bench.   
 
Extra specimens are placed in the biohazard bucket labeled for peripheral bloods located 
under the tissue culture hood. Samples will be retained for 10 days as a back-up if 
needed. 
 
Bloods set up the same day should be in one bag labeled with the set up date. 
 
All tissue culture incubators are on emergency power. 
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APPENDIX G 
 
Basic Culture of Bone Marrow and Leukemic Blood 
Principle:  This procedure utilizes methods devised by Jorge Yunis, Avery Sandberg and 
others for culture and chromosome analysis of blood and bone marrow cell in human 
hematologic malignancy.   
Clinical Significance: Cytogenetic studies help classify malignant hematologic disorders 
that are associated with specific chromosome abnormalities.  Cytogenetic subclones 
provide clues to disease progression.  Cytogenetics also is useful to assess the 
effectiveness of treatment and to monitor remission. 
Specimen:  Bone marrow and blood in sodium heparin. Store the sample at room 
temperature if culture cannot be established the same day.  NOTE:  Samples will be 
accepted in purple and yellow top tubes with the caveat that a study cannot be 
guaranteed.  See 
Equipment/Materials:   
1.  Culture Flasks (Falcon # 29185-078) 
2.  Falcon Centrifuge Tubes (# 352009 for 15 mL)  
3.  Pipets (Falcon #7551 for 10.0 mL, #7543 for 5.0 mL, #7521 for 1.0 mL) 
4.  Colored Tape (Fisher# 159015) 
5. Drummond Pipet-Aid (Fisher# 4-000-110) 
6. Laminar Flow Hood (Baker Steri Guard# 92859) 
7. Centrifuge (Thermo Scientific Sorval ST-16 50120982-5) 
 
Reagents/Media: 
 1.  Media A:  Marrow Max ( 12260-014) store frozen media at -5 to -25oC. Thaw as 
needed, store at 2-8 oC. Use at room temperature (22 oC to 24 oC).  
2.   Media B:  Chang Marrow (Irvine Scientific # 91031) store frozen media at -5 to -
25oC. Thaw as needed, store at 2-8 oC. Use at room temperature (22 oC to 24 oC).  
3.  RPMI (Gibco# 61870) store at 2-8 oC. Use at room temperature (22 oC to 24 oC).  
4.  Collagenase Solution:   RPMI 1640  (Gibco 1187-093) store at 2-8 oC,Dnase 100 mg – 
(Sigma DN-25) -5 to -25oC,HBSS  (Gibco 14175-079) store at 2-8 oC,BMR type B 
collagenase – (Roache Diagnostics 1 088 823) -5 to -25oC,0.45µ filter (3 or 4 filters) 
(Fisher 0974028f) 
Resuspend 100 mg of Dnase in 10.0 mL of HBSS.  Split into 5.0 mL aliquots.  Freeze 
remaining aliquot at -5 to -25oC .    To 95.0 mL of RPMI 1640 add 5.0 mL of Dnase 
solution (step 1).  Add one l.0 gm vial of BMR type B collagenase to the RMPI.  Cover 
and shake to dissolve.  (rinse collagenase vial to get any retained powder.)  When 
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completely dissolved, filter solution using a 0.45µ filter (you’ll need 3 or 4).  Aliquot in 
1.0 mL aliquots.  Freeze at -5 to -25oC until needed. 
 
Procedure: Culture the cells using universal precautions working in the laminar flow 
hood. 
• SAMPLES ARE TO BE SET UP IN NUMERICAL ORDER AS THEY ARE 
RECEIVED IN THE LABORATORY, WITH ONLY ONE SAMPLE AT A TIME 
IN THE HOOD.   
• CREATE PATIENT LABELS AND TRANSFER CENTRIFUGE TUBE FOR 
ONE SAMPLE AT A TIME AS YOU WORK ON THAT SPECIFIC SAMPLE IN 
THE HOOD.  
• TUBES/FLASKS MUST BE LABELED WITH PATIENT NAME, DATE AND 
ACCESSION NUMBER BEFORE YOU ADD THE PATIENT SAMPLE.   
 •THE PATIENT CULTURE SHEET IS BROUGHT INTO TISSUE CULTURE   
AND RETURNED TO THE PATIENT CHART AFTER THE SET UP 
INFORMATION IS FILLED OUT. 
If a sample is a new diagnosis APML or pediatric B-ALL, this is a RUSH case.  Set up an 
extra culture (C culture) for early morning harvest (place this culture in a separate rack 
labeled with the day of the week to be harvested and put in A incubator).   
1. Perform the cell count following the TC-20 Cell Count protocol.  
 
Protocol:  TC-20 Automated Cell Count of leukemic blood and bone marrow 
samples 
Principle:  Count the live White Blood Cells (WBC) after lysis of Red Blood Cells 
(RBC). 
Clinical Significance:  The live WBC count is used to determine the appropriate 
(correct) sample amount to inoculate short term hematologic cultures. These cultures will 
be harvested and used for metaphase and interphase analysis for karyotype and FISH 
(fluorescent in situ hybridization).  
Equipment/Materials:   
A. TC 20 automated cell counter. Bio-Rad.  Cat# 145-0101. 
B. Laminar Flow Hood. Baker SG 403A 
C. Micropipette  Pipet-Lite XLS Ranin 10-50ul 
D. Micropipette tips  Fisher 1-200 ul 2707502 
E. Sterile 15 ml centrifuge tubes Falcon 352099  
F. Bio-Rad Counting Slides, Dual Chamber for Cell Counter. Cat# 145-0011. 
G. Nikon inverted microscope 
H. Micro Centrifuge 
Reagents/Media: 
A. Leuko-Tic VT Viability Test kit.  Bioanalytic. Ref. 004005-6100.  Each kit 
contains leuko-tic vials and trypan blue staining solution. 
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 Procedure:   
1.  Turn on the TC-20 cell counter.  The green power button is located on the right lower 
side of the counter.  Using the micro centrifuge spin down a vial of Leuko-tic for 5-10 
seconds. 
2.  Transfer any samples received in syringes into a labeled centrifuge tube with the 
patient accession label. 
3.  Place patient accession label on the Leuko-tic vial.   
4.  Add 20 µl of patient sample into the leukotic vial.   
5.  Mix well by pipetting up and down ten to twelve times.   
6.  Set the timer for 5 minutes and wait 5 minutes to proceed to step7. 
7.  Add 20 µl of leukotic trypan blue solution to the sample.   
8.  Mix well by pipetting up and down twenty times to insure homogeneous sample. 
NOTE:   Handle the TC-20 counting slides using the edges and avoid touching the 
optical surface of the slide.  
9.  Label the slide with the patient CG number.  
10. Place the pipette tip at a 45 degree and touch the half circle dispensing 10 µl of 
patient sample at the bottom of the sample loading area (half circle at outer edge of 
chamber).  Repeat the process with the other chamber on the slide. 
11. Insert the counting slide into the slide slot of the TC-20 cell counter. 
12. The counter will detect the presence of the slide and initiate the count. 
13. The count results will appear on the count screen.  Document the cell count on the 
culture sheet, remove the slide . 
14. Insert the uncounted end in the TC-20 and document the count on the culture sheet.  
15.  Remove the slide from the machine.  Press home. 
16.  Dispose of the patient sample vial and slide in the biohazard container. 
Results Reporting:   
1.  Write all results on the patient culture sheet..Adjust the count to the same exponent.  
Example:  2.5x105 = .25x106. 
2.  Add count one and count two.  Divide by 2 for the average. 
3.  Multiply the average by 10.  This is the final cell count. 
4.  Use the cell count table for the amount of sample to add to the patient culture. 
Method Performance Specification/Limitations 
A.  A cell count above the specified range (1x107) reading will display "Uncountable" on 
the count screen.  A cell count below the range (5x104), "Value out of range" or 
"uncountable" will be displayed on the count screen. If either appears, check the slide on 
the Nikon inverted phase microscope (wet lab) to confirm cell density.  
B. If cell count is above 1x107 then dilute sample in half with media and repeat TC-20 
cell count.  
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Basic culture: 
1.  Add 5.0 mL media A to the first flask and 5.0 mL of media B to the second flask.  
2.  Create 2 labels using the same colored tape with the following: patient accession 
number, date, patient’s last name, and A or B to denote media lot.  Note: If there is 
not enough specimen for 2 cultures, create one culture and label the flask A only.  If a 
small amount of sample is left set up the remaining sample and label the flask 
“wash”.  
3.   Check the patient name on the tube/syringe/sample bag to see that it matches all 
included labels and the corresponding set up sheet. If the sample is in a tube and does 
not need to be transferred, affix a preprinted cytogenetics label to the tube. If the 
sample is in a syringe, place a preprinted cytogenetic label on a 15.0 mL centrifuge 
tube and then transfer the sample into the pre-labeled tube.  Place the patient labels on 
the flasks. Use gauze to remove cap on syringe/tube to prevent any bone 
marrow/blood from splattering/spilling.   
4.  Incorrect anticoagulant (wrong colored tube Lithium Heparin, a yellow top or a purple 
(EDTA) prepare the sample for culture by washing it. This will hopefully rinse away the 
anti-collagulant that will interfere with growth.  
A. Wash the sample 2 times by transferring the sample into a 15 mL centrifuge 
tube (place up to 4.0-5.0 mL of sample the tube). Add 8.0-10.0 mL of RPMI 
depending on the amount of sample in the tube (be careful not to overfill). 
B. Centrifuge 10 minutes at 1000 rpm to “wash” the anticoagulant out of the 
specimen. Aspirate off the RPMI. Repeat.  Aspirate off the RPMI and set-up the 
sample as usual adding 0.2 mL extra sample to each culture if possible.   
C. Add 1/2 vial (0.25 mL) of thawed collagenase to each flask (see reagents and 
solutions) to prevent clotting.   
5.  Clotted sample:  With the pipette, try to break up the clot as much as possible.  Add 
one tube of collagenase to each flask if the sample is very clotted.  Add 1\2 of a tube to 
each flask if the sample is slightly clotted. 
6.   Add the amount of sample corresponding to the WBC count on the live blood count 
table.  Cap loosely and swirl specimen to mix. (A loosely capped culture flask ensures 
sufficient CO2 exchange.)  Place the remaining sample and empty syringe back into 
the patient’s labeled biohazard bag. 
7.  Record culture information on form 3 (LM culture set up sheet).  Document any 
sample issues such as inadequate sample, clotted sample or wrong sample tube in the 
comment section of the tissue culture sheet. Also, please document any sample 
volume adjustments that you made to the cultures.  
 
8.  Record the case number(s) on the appropriate harvest list located on the incubator 
door. 
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9.  Place the cultures in the A and B incubators and in the appropriate racks for next day 
harvest. 
 
10.  Incubate overnight (15-24 hours). 
 
11.  Remove the remainder of sample/empty sample container in its original sample bag 
and place the sample in the red biohazard bucket specifically labeled for daily 
samples.    The sample/containers will be saved for two weeks (or until the sample is 
signed out) in the cold room. 
 
12. File the Tissue Culture set up sheet in the patient chart.  
 
13. Bone marrow samples that show a balanced translocation that is not indicative of a 
specific leukemia may require a constitutional karyotype. Give the left-over sample to 
the tumor group for fibroblast culture. 
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APPENDIX H 
 
"AUTOMATED HANABI PROTOCOL"  
HARVESTING PERIPHERAL BLOOD CULTURE "A"  
 
 
1. Add contents of tube #2 into tube #1 and label as culture "A." 
 
2. (If tubes #5 and #6 are available, they are combined and harvested using the A 
harvest protocol and labeled as culture “C”). 
 
3. Add 100 µL of Colcemid to the tube(s), invert, and incubate at 37˚C for 20 
minutes. 
 
4. Turn on Hanabi by pressing power button and turn on the light. 
Let the machine warm up.  The screen will show main menu “HANABI-PII.” 
 
5. Fill the water carboy with DIUF water (Fisher W2-4 # 7732-18-5) if near the 
“lower” water line (carboy B located under the Hanabi on the bottom shelf). 
 
6. Fill the water carboy with deionized water if near the “lower” water line (carboy 
A located under the Hanabi on the bottom shelf).  
 
7. Replace the water bottles on the side of the Hanabi with 0.075M KCL hypotonic 
solution and fresh fixative (3:1methanol: acetic acid).  
 
8. At this time the fixative solution should be placed in a Styrofoam container with 
ice  (the Hanabi solution tubes are labeled accordingly).  
 
8 Tubes 340 mL of fix 
12 Tubes 440 mL of fix 
16 Tubes 540 mL of fix 
 
9. On the touch screen press “reagent exchange” (pump drying is not used at this 
step).  
 
10. Select “origin” to reset the centrifuge placement. 
 
11. Press “start” under “hypotonic solution” (the machine will flush the lines with 
fresh hypo) when the exchange is finished press “start” under “fixative 
solution” (the machine will flush the lines with fresh fixative) when the 
exchanges is finished, press “main” to go back to main screen. 
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12. Press “select protocol” on the touch pad. 
 
13. Select "B" for harvest “main process” on the touch pad. 
 
14. Then press the arrow on the touch prep: Select “main process.” 
 
15. Select the number of samples 8, 12, or 16.  
 
16. Press “set sample start” to localize the Hanabi (i.e. orient bucket # 1 to 6 o'clock 
position).  
 
17. Load your first four tubes in bucket #1.   
If you have blanks put a blank in the first slot and then anywhere else you would 
like during the loading of the centrifuge (blanks need to be filled with water at the 
same volume as the other culture tubes). 
 
18. Press “next” to advance the centrifuge to the next bucket after you hear the beep 
Continue doing this until the centrifuge is loaded.  
 
19. Close the centrifuge cover. 
 
20. Press “main start” You will need to hold down the touch pad until you hear a 
beep. 
 
When the Hanabi run is complete 
 
21. Press “start” (this will stop the beeping sound). 
 
22. Lift centrifuge lid and remove the 1st bucket of samples. Remove one sample tube 
at a time and re-cap. Double-check the number on the cap with the number on the 
tube. 
 
23. Press “next” and wait for the beep. Continue with this process until all samples 
have been removed. 
 
24. Press “comp”. If finished for the day, proceed to step 5.  If not finished for the 
day, leave the machine on.  
 
When Harvesting is finished for the day  
 
25. Select "tube washing" press “start” next to the set key. 
 
26. Place DIUF water filled 15 mL centrifuge tubes in bucket #1 (4 tubes).  
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27. Press “start” next to the wash key. 
 
28. When the tube washing is finished, press “start” next to the remove key, remove 
tubes, close centrifuge lid. 
 
29. Press “main” (you will have to hold down this command on the touch screen for 
a couple of seconds). 
 
30. Select “reagent exchange.” 
 
31. Replace hypo and fix bottles with the water bottles containing DIUF water. 
 
32. Press “5 min” under pump drying. 
 
33. While pump drying, press “start” under “hypotonic solution” (the machine will 
flush the lines with DIUF water, when the exchange is finished press “start” 
under “fixative solution” (the machine will flush these lines with DIUF water). 
 
34. Once the reagent exchange and the pump drying is finished “press main”, this 
will bring you back to the main menu.   
 
35. Turn off the machine by pressing the "power button" and turn off the light. 
 
 
Helpful Hints 
 
If the Hanabi gives an error message and you are unable to fix the run, press “origin.”  
This will automatically move any of the mechanical arms away from the centrifuge 
bucket so that the samples may be removed from the Hanabi and the run can be finished 
manually.   
 
Technical help  
 
Robert Burfield 1-814-280-2238 and John McCloskey 1-617-504-3120 
Support Line 1-888-233-9283 
 
Document the error for troubleshooting or to call for repairs.  Notify the Technical 
Director of any problems in need of repair or attention. 
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HANABI ITEM-SET PROTOCOL 
- After turning on the HANABI choose: "select Protocol" 
- Choose: "B" protocol, select NEXT 
- Choose: "ITEM SET" 
• B1 
o A: Centrifuge Time [60-600][sec]  420 
o B: Aspirate Level [120-138][mm]  125 
o C(1): Inject Hypotonic [1.00-6.00][mL] 4.50 
o C(2): Stirring Time [1-20][sec]  07 
o ABC: Process Count [1-2][Time]  2 
• B2 
o G(1): Inject Fixative [0.25-5.00][mL] 1.0 
o G-Process:  
 
o Stir: 
 
o G(2): Stirring Time[1-20][sec]  07 
o H: Centrifuge Time[60-600][sec]  420 
• B3 
o I: Aspiration Level 
 [I1] [107-138][mm]  127 
 [I2] [107-138][mm]  129 
 [I3] [107-138][mm]  129 
 [I4] [107-138][mm]  129 
 [I5] [107-138][mm]  129 
• B4 
o J: Inject Fixative 
 [J1] [1.00-5.00][mL]  5 
 [J2] [1.00-5.00][mL]  5 
 [J3] [1.00-5.00][mL]  5 
 [J4] [1.00-5.00][mL]  5 
 [J5] [1.00-5.00][mL]  5 
• B5 
o J: Stirring Time [1-20][sec]  07 
o K: Centrifuge Time [60-600][sec]  420 
o Total Hypotonic Time [600-3000][sec] 1370 
• B6 
o IJK 
PROCES
5 4 3 2 1 
EXE SKIP 
After 
Injection 
During 
Injection 
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S: 
 
o Count 
Setting: 
 
o Aspirate 
Level: 
 
o Inject Fixative: 
J1 J2 J3 J4 J5 
5.00 5.00 5.00 5.00 5.00 
 
 
Inner Door Settings: 
o Stirring Motor: 
- SC-1: Fixative Stir for A+B, set to "12" 
- SC-2: Hypotonic Sit for A+B, set to "42" 
o Air Bath: 37°C 
o PreHeat: 37°C 
o Tube Detector: 
 -ABCD Readers should have a detection of ≥ (-1000) to 
indentify when a tube is in place. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 2 3 4 5 LAST 
I1 I2 I3 I4 I5 
127 129 129 129 129 
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APPENDIX I 
 
"AUTOMATED HANABI PROTOCOL"  
HARVESTING PERIPHERAL BLOOD CULTURE "B"  
 
 
36. Add contents of tube #4 into tube #3 and label as culture "B." 
 
37. Add 100 µL of ethidium bromide (Sigma #E1385 - 500 µg/mL) to the tube(s), 
invert, and incubate at 37˚C for 60 minutes. 
 
38. Add 100 µL of Colcemid to the tube(s), invert, and incubate at 37˚C for 20 
minutes. 
 
39. Turn on Hanabi by pressing power button.  Turn on the light. 
Let the machine warm up, it will go to main menu “HANABI-PII.” 
 
40. Empty the fix waste carboy if the fix volume is getting near the waste full line 
(carboy B located under the Hanabi on the bottom shelf).  
 
41. Fill the water carboy with DIUF water (Fisher W2-4 # 7732-18-5) if near the 
“lower” water line (carboy A located under the Hanabi on the bottom shelf). 
 
42. Replace each water bottle on the side of the Hanabi with 0.075M KCL hypotonic 
solution and fresh fixative (3:1methanol: acetic acid), respectively. 
 
43. At this time the fixative solution should be placed in a Styrofoam container with 
ice  (the Hanabi solution tubes are labeled accordingly).  
 
8 Tubes 340 mL of fix 
12 Tubes 440 mL of fix 
16 Tubes 540 mL of fix 
 
44. On the touch screen press “reagent exchange” (Pump drying is not used at this 
step).  
 
45. Select “origin” to reset the centrifuge placement. 
 
46. Press “start” under “hypotonic solution” (the machine will flush the lines with 
fresh hypo) when the exchange is finished press “start” under “fixative 
solution” (the machine will flush the lines with fresh fixative) when the 
exchanges is finished, press “main” to go back to main screen. 
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47. Press “select protocol” on the touch pad. 
 
48. Select "B" for harvest “main process” on the touch pad. 
 
49. Press the arrow on the touch prep: Select “main process.” 
50. Select the number of samples 8, 12, or 16  
 
51. Press “set sample start” to localize the Hanabi (i.e. orient bucket # 1 to 6 o'clock 
position).  
 
52. Load first four tubes in bucket #1.   
If you have blanks put a blank in the first slot and then anywhere else you would 
like during the loading of the centrifuge (blanks need to be filled with water at the 
same volume as the corresponding culture tubes) 
 
53. Press “next” to advance the centrifuge to the next bucket after the beep. 
Continue doing this until the centrifuge is loaded.  
 
54. Close the centrifuge cover. 
 
55. Press “main start” You will need to hold down the touch pad until a beep has 
sounded. 
 
When the Hanabi run is complete: 
 
56. Press “start” (this will stop the beeping sound). 
 
57. Lift centrifuge lid and remove the 1st bucket of samples. Remove one sample tube 
at a time and re-cap. Double-check the number on the cap with the number on the 
tube. 
 
58. Press “next” and wait for the beep. Continue with this process until all samples 
have been removed. 
 
59. Press “comp”. If finished for the day, proceed to step 5.  If not finished for the 
day, leave the machine on.  
 
When Harvesting is finished for the day:  
 
60. Select "tube washing" press “start” next to the set key. 
 
61. Place DIUF water filled 15 mL centrifuge tubes in bucket #1 (4 tubes).  
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62. Press “start” next to the wash key. 
 
63. When the tube washing is finished, press “start” next to the remove key, remove 
tubes, close centrifuge lid. 
 
64. Press “main” (you will have to hold down this command on the touch screen for 
a couple of seconds). 
 
65. Select “reagent exchange.” 
 
66. Replace hypo and fix bottles with the water bottles containing DIUF water. 
 
67. Press “5 min” under pump drying. 
 
68. While pump drying, press “start” under “hypotonic solution” (the machine will 
flush the lines with DIUF water, when the exchange is finished press “start” 
under “fixative solution” (the machine will flush these lines with DIUF water). 
 
69. Once the reagent exchange and the pump drying is finished “press main”, this 
will bring you back to the main menu.   
 
70. Turn off the machine by pressing the "power button" and turn off the light. 
 
 
Helpful Hints 
 
If the Hanabi gives an error message and you are unable to fix the run press “origin” this 
will automatically move any of the mechanical arms away from the centrifuge bucket so 
that the samples may be removed from the Hanabi and the run can be finished manually. 
 
 
Technical help  
 
Robert Burfield 1-814-280-2238 and John McCloskey 1-617-504-3120 
Support Line 1-888-233-9283 
 
Document the error for troubleshooting or to call for repairs.  Notify the Technical 
Director of any problems in need of repair or attention. 
 
 
 
 
  
HANABI ITEM-SET PROTOCOL 
- After turning on the HANABI choose: "select Protocol" 
- Choose: "B" protocol, select NEXT 
- Choose: "ITEM SET" 
• B1 
o A: Centrifuge Time [60-600][sec]  420 
o B: Aspirate Level [120-138][mm]  125 
o C(1): Inject Hypotonic [1.00-6.00][mL] 4.50 
o C(2): Stirring Time [1-20][sec]  07 
o ABC: Process Count [1-2][Time]  2 
• B2 
o G(1): Inject Fixative [0.25-5.00][mL] 1.0 
o G-Process:  
 
o Stir: 
 
o G(2): Stirring Time[1-20][sec]  07 
o H: Centrifuge Time[60-600][sec]  420 
• B3 
o I: Aspiration Level 
 [I1] [107-138][mm]  127 
 [I2] [107-138][mm]  129 
 [I3] [107-138][mm]  129 
 [I4] [107-138][mm]  129 
 [I5] [107-138][mm]  129 
• B4 
o J: Inject Fixative 
 [J1] [1.00-5.00][mL]  5 
 [J2] [1.00-5.00][mL]  5 
 [J3] [1.00-5.00][mL]  5 
 [J4] [1.00-5.00][mL]  5 
 [J5] [1.00-5.00][mL]  5 
• B5 
o J: Stirring Time [1-20][sec]  07 
o K: Centrifuge Time [60-600][sec]  420 
o Total Hypotonic Time [600-3000][sec] 1370 
• B6 
o IJK PROCESS: 
 
5 4 3 2 1 
EXE SKIP 
After 
Injection 
During 
Injection 
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o Count Setting: 
 
o Aspirate 
Level: 
 
o Inject Fixative: 
J1 J2 J3 J4 J5 
5.00 5.00 5.00 5.00 5.00 
 
 
Inner Door Settings: 
o Stirring Motor: 
- SC-1: Fixative Stir for A+B, set to "12" 
- SC-2: Hypotonic Sit for A+B, set to "42" 
o Air Bath: 37°C 
o PreHeat: 37°C 
o Tube Detector: 
 -ABCD Readers should have a detection of ≥ (-1000) to indentify 
when a tube is in place. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 2 3 4 5 LAST 
I1 I2 I3 I4 I5 
127 129 129 129 129 
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APPENDIX J 
 
“Automated Hanabi protocol” for the harvesting of Leukemic Blood and Bone Marrow 
 
During the harvest, the cells are treated with ethidium bromide to minimize chromosome 
condensation.  Colcemid is added to arrest cells in metaphase, and a hypotonic KCL solution to 
induce cellular swelling.  The cells are then fixed with methanol/glacial acetic acid to thin the 
cellular membrane and chromosome spreads are prepared. 
 
Materials:  
• 15.0 mL centrifuge tubes (Falcon # 352009) 
• 10.0 mL pipets (Falcon #7551) 
• 200 µL pipets tip (Fisher 21-197-8H sterilized) 
• ethidium bromide (stored at 2-8 oC.)  (Sigma E-1385 500 µg/mL) 
• colcemid stored at 2-8 oC (Irvine Scientific  # 9311 10 µg/mL) 
• 0.075 M KCL:  To 2.0 liters distilled H2O add 11.8g KCL (Fisher A38-500) stored at 15 
oC to 30 oC. 
• 3:1 methanol/glacial acetic acid fixative (Fisher Methanol A412-1, Fisher Acetic Acid 
A38-500) 
• D.I.U.F. water (Fisher CAS 7732-18-5) 
 
Work in Laminar Flow Hood. Wear Lab Coat/Gown and gloves. 
When harvesting, be sure to harvest the A-side FISH only cultures in the first harvest of 
the day.  
 
Stimulated cultures (CpG cocktail and interleukin 4) are harvested without ethidium 
bromide.  Proceed to step 2 of the protocol omitting step 1. 
 
1.  Add 50 µL ethidium bromide to each culture and swirl gently to mix.  Incubate 1.5 hours.  
 
2 At the end of the ethidium bromide treatment, add 100 µL colcemid to each culture and gently 
mix.  Transfer culture label and the contents of the culture one at a time to 15.0 mL centrifuge 
tubes ONLY ONE SAMPLE AT A TIME IS TO BE WORKED ON..    Proceed to the next 
flask/culture. When finished transferring all the samples for harvest, label the tube caps with the 
patient number and culture (A or B). Incubate 20 minutes.  
 
1) Turn on machine by pressing power button and turn the light on. 
2) Let the machine warm up-it will go to main menu. “HANABI-PII” 
3) Empty the fix waste container if the fix volume is getting near the fill line. Fill the 
water carboy with deionized water if near the “lower” water line.   
Replace the H20 bottles on the side of the machine with 0.075M KCL hypotonic solution 
and fresh (3:1)(methanol:acetic acid) fixative (otherwise the chemicals will be stored in 
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the flammable and acid cabinets). At this time  the fixative solution should be placed in a 
container with ice.  (The solution tubes for the Hanabi are labeled appropriately.)  the 
fixative solution should be placed in a container with ice.  (The solution tubes for the 
Hanabi are labeled appropriately.)  
 
8 Tubes 340 mL of fix 
12 Tubes 440 mL of fix 
16 Tubes 540 mL of fix 
 
 
4) On the touch screen press “reagent exchange”.  (Pump drying is not used at this 
step). Select “origin” to reset the centrifuge placement. 
5) Press “start” under “hypotonic solution” (the machine will flush the lines with 
fresh hypo) when the exchange is finished press “start” under “fixative solution” 
(the machine will flush the lines with fresh fixative) when the exchanges is finished 
Press “main” to go back to main screen. 
6) Press “select protocol” on the touch pad. 
7) Select B for bone marrow harvest “main process” on the touch pad. 
8) Then press the arrow on the touch prep. Select “main process”.  
9) Select the number of samples 8,12,16.  
10) Press “set sample start” (this should localize the Hanabi so that the bucket 1 will be 
at 6:00.)  Load your first four tubes in the bucket 1.  If you have blanks put a blank in 
the first slot and then anywhere else you would like during the loading of the 
centrifuge. (Blanks need to be filled with water to the same volume as the cultures.) 
11) Press “next”: to advance the centrifuge to the next bucket after you hear the beep. 
Continue doing this until the centrifuge is loaded. Close the centrifuge cover. 
12) Press “main start” You will need to hold down the touch pad until you hear a beep. 
When the Hanabi run is complete 
1)  Press “start”  (This will stop the beeping sound) 
2) Lift centrifuge lid and remove the 1st bucket of samples. Take one sample at a time and 
replace with the centrifuge cap. Double-check the number on the cap with the number on 
the tube.  
3) Press “next”- and wait for the beep. Continue with this process until all samples have been 
removed. 
4) Press “comp”. If finished for the day, proceed to step 5.  If not leave the machine on.  
When finished for the day  
5)  Select tube washing press “start” button next to the set key. 
6) Place deionized H20 filled test tubes in bucket 1 (4 tubes).  
7) Press the “start” button next to the wash key. 
8) When the tube washing is finished, press “start” button next to the remove key, remove 
tubes, close centrifuges lid. 
9) Press “main” (you will have to hold down this command on the touch screen for a couple 
of seconds) 
10) Select “reagent exchange” 
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11) Replace hypo and fix bottles with the water bottles containing D.I.U.F.water. 
12) Press “5 min.” under pump drying. While pump drying,  
13) Press “start” under “hypotonic solution” (the machine will flush the lines with deionized 
water, when the exchange is finished press “start” under “fixative solution” (the machine 
will flush these lines with deionized water).  
14) Once the reagent exchange and the pump drying is finished “press main”, this will bring 
you back to the main menu.  Turn off the machine by pressing the power button and turn 
off the light.  
 
 
 
Helpful Hints 
1. If the machine gives an error message and you are unable to fix the run press “origin”.  
This will automatically move any of the mechanical arms away from the centrifuge 
bucket so that the samples may be removed from the machine and the run finished by the 
hand method. 
2. For technical help call:   Robert Burfield 1-814-280-2238,  Keith Weirich  1-281-788-
7490, John McCloskey 1-617-504-3120, Support Line 1-888-233-9283 
3. Document the error so that the machine can be troubleshot or we need to call for repairs.  
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APPENDIX K 
Preparation of Chromosome Spreads-Slide making 
Principle:  Good quality G banding is dependent on slide preparation. Multiple variables will 
affect the quality of the slide. These include properly harvested cells, temperature, humidity, 
drying time and the number of cells per slide.   
 
Specimen:  Fixed cell pellet from leukemic blood, bone marrow, lymph node, spleen, core 
biopsy and any other samples harvested for cytogenetic analysis. 
 
Materials/Equipment: 
 
Microscope Slides (Fisher 12-550-15) 
Pasture pipettes (Fisher 9” cat. # 13-678-20C, 5 ¾ “ 13-678-20A) 
Securline/Histoprep (permanent) Marker  (Fisher1450-20-FSC) 
Phase contrast microscope 
Slide warmer 
Pasture Pipette bulbs 
Water bath 
 
 Reagents:  store both and use at room temperature (15 oC to 30 oC) 
 
methanol (Fisher Methanol A412-1) 
acetic acid (Fisher Acetic Acid A38-500) 
 
Prepare fresh 3:1 methanol:acetic acid 
 
1. Remove tubes containing the fixed cells from refrigerator.  If the cells are not pelleted 
centrifuge 10 minutes at 1000 rpm. 
 
2.  Remove and discard supernatant. Gently resuspend each pellet in ~0.5 to 3.0 mL fresh 
fixative; depending upon the appearance and density of the pellet (the suspension should be 
slightly cloudy). 
 
WORK ON ONLY ONE CASE AT A TIME 
 
3.  Draw a small sample of cell suspension into a Pasteur pipette.  From a height of ~3 inches to 
2 feet, drop 4 to 5 drops onto a cold/room temperature, wet/dry precleaned microscope slide 
(labs vary and it is best to try several different methods to find out what is best for your lab).  
Gently blow across the slide surface. Humidity from a water bath can be added at this point to 
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help spreading. Allow slide to dry.  (Slides may be placed on a slide warmer at 55.0-60.0 oC to 
dry.) 
 
4. Label the slide to be dropped with the case number, patient last name, culture A or B and 
subsequent slide number, i.e. A-1, B-2 etc. 
 
Cells should not be suctioned past the stem of the Pasteur pipette as they will become trapped in 
the body of the pipette and will not be retrievable. 
 
5. Check the slide for number and quality of chromosome spreads using a phase-contrast 
microscope.  (If spreading appears inadequate, make necessary adjustments).  Make 2 slides if 
possible, but due to the miotic index and morphology extra slides may be dropped from each 
culture.  Note:  if no metaphases are seen hold a portion of the sample until the cytogenetics can 
be read.  Depending on the results and diagnosis FISH studies may be appropriate.  If the cell 
pellet is minimal~invisible, please be sure to retain a portion of the pellet for possible FISH 
studies. If the case is a study patient for CML and labeled 20 metaphases make sure to make 
extra slides so the 20 metaphases may be obtained.  Always save a part of the pellet for FISH 
analysis. 
 
6.  Record slide making info onto the culture sheet found numerically in the Bone Marrow 
culture sheet binder. Document the number of slides dropped per culture, date, technologist 
quantity and quality of metaphases and if interphase cells are available for FISH. 
 
7.  Add 1.0~2.0 mL fixative to remaining pellet; save pellet for potential FISH studies. 
 
8. Bake slides for approximately 1 hour 20 minutes to 2 hours in an 85.0-90.0o C oven.   
 
9. Once the cases are finished the leftover pellets will be stored at 4oC in the cold room. 1-2 
months after sign-out the pellets will be frozen down at -5 to -25 oC.  
 
10. If the Molecular Lab needs our fixed pellet or our original sample for additional testing, 
document in power path that the pellet/sample was given to the Molecular Lab. 
 
STAT preparation of slides: 
 
1.  STAT cases are dropped and aged in the oven as usual.  The technologist may want to drop 
extra slides and remove a slide after 1 hour to 1 hour 20 minutes of baking.   
Allow slides to completely cool and proceed with Geimsa-Trypsin banding adjusting the times as 
suggested in the Giemsa Banding protocol. 
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2.  Alternative Microwaving technique: rather than oven baking the slides, extra slides may be 
dropped in addition to the normal ones to microwave. This allows the slides to age faster.  
Microwave the slides for 5 minutes.  Allow slides to completely cool and proceed with Geimsa-
Trypsin banding adjusting the times as suggested in the Giemsa Banding protocol. 
  
Reference:  The AGT Cytogenetics Laboratory Manual (Third Edition) 1997 
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APPENDIX L 
 
FISH ON CHORIONIC VILLI (CVS) 
 
 
1. A prenatal tech will prepare the slides for FISH. Store additional unused slides in the freezer.  
2. Label the slide as below: 
 
 
 
 
 
 
 
 
3.  Dehydrate in 70%, 80%, 90%, and 100% ethanol (room temperature, 59°F to 86°F)  
 for 2 minutes each.    
4.  Allow slides to air dry.   
4.  Remove the probes from the freezer and warm them for at least 5 minutes in the drawer under 
the FISH bench. Vortex and then spin down the probes using the vortex on the FISH 
bench. 
5. Add 3.8 µL probe under a 12 mm circular cover slips, and cover with a piece of 
 parafilm.   
6. Place the slide on the HyBrite and co-denature probe and cells together for 2 minutes  at 
80oC. 
7. Incubate the slide overnight at 37oC. 
8. Remove parafilm and cover slip and place the slide in 0.4X SSC/0.3% Tween 20 (pH7.0) at 
73oC for 2 minutes. (Do not wash more than 4 slides at a time) 
9.  Remove the slide(s) and place in the 2X SSC/0.1% Tween 20 (pH 7.0) for 1 minute. 
10. Transfer slides to 1X PBD at room temperature (59°F to 86°F) 
11. Counterstain with 10 uL of DAPI II/Antifade and cover the slide with a 24 x 50 mm   
 coverslip.  
 
Data Collection/Comments 
 
1.  Two readers count nuclei with 1, 2, 3 or more hybridization signals and score a minimum of 
50 nuclei per probe. If 50 nuclei cannot be counted, the result should be considered inconclusive.  
 
2.  Each reader records their data from scope analysis on 2 separate standardized data collection 
form (see attached form).  The patient name and case number are to be “checked” on the scope 
        CG # 
      Patient  Name 
 
           L       R 
      X,Y,18  /13,21   
        
                L                      R              month day      
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sheet by each reader to verify that the patient identifiers match the identifiers on the slides to be 
scoped. 
 
3.  The second reader will average the scores of the two readers and record the result of the assay 
in the Result field on the form. 
 
4.  Capture images of four nuclei per probe using the Applied Imaging CytoVision system. 
  
5. For a result to be considered disomic (or trisomic), at least 70 % of the cells must show two 
signals (or three signals). 
 
6.  FISH for 22q11.2 on CVS will be performed on a cover slip with metaphase chromosomes. 
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APPENDIX M 
 
FISH ON CULTURED PERIPHERAL BLOOD LYMPHOCYTES 
 
Specimen Processing   (Performed by Blood Techs) 
 
1.  Record sample in FISH/peripheral blood log book. 
 
2. Process the specimen according to protocol in the Standard Operating Manual for   
     Peripheral  Blood Lymphocytes. 
Slide Making 
 
1. Soak slides in deionized water. 
 
2. Remove tubes with harvested blood cells from oC coldroom. Centrifuge at 1000 rpm for 10 
minutes.  Aspirate supernate to a level slightly above the pellet.  Add 10 mL of fresh fixative (3:1 
methanol:acetic acid) and spin at 1000 rpm for 10 minutes. Aspirate supernate to a level slightly 
above the pellet.  Add fresh fixative to make a slightly turbid cell suspension. 
 
3. Drain excess water from a Superfrost Plus slide with a paper towel by tapping edge of slide on 
a paper towel. 
 
4. Using a pasteur pipette, place one or two drops of cell suspension per slide from eye level, in 
the middle if using a single probe or on each end of the slide if using two probes.  Blow once 
across the slide and let it air dry. 
 
5. Check metaphase spreading and chromosome morphology using phase contrast microscopy. 
 
6. Label each slide with CG#, last name, and FISH # (e.g. FISH 22).  Use a Fisherbrand 
SuperFrost marker or a pencil to prevent ink from running. Store slides in dessicator at room 
temperature (59°F to 86°F) or use them directly for FISH.   
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FISH  
 
1. Incubate slides for 30 minutes in 2X SSC (pH 7.0) in a coplin jar in a waterbath pre-warmed 
to 37oC.  Dehydrate slides in 70%, 80%, 90%, and 100% ethanol series for 2 minutes in each jar.  
Air dry. 
 
2.  Pre-warm the probes by placing them in the top drawer on the FISH bench for at least 5 
minutes, then spin briefly in the mini centrifuge prior to applying them to the slides.  
 
3. Apply 9.5 µL of probe, cover with a 22x30mm cover slip and seal carefully with rubber 
cement, use 22x22mm cover slips if using 2 probes per slide.  
 
4. Denature probe and cells together at 80oC on the HYBrite slide warmer.  
     *** 1 minute for metaphase spreads 
 *** 2 minutes for interphase cells 
 
5. Incubate overnight at 37oC in the FISH incubater in the tissue culture room. 
 
6. Remove rubber cement and cover slip and place in 0.4X SSC/0.3% Tween 20 (pH 7.0) at  
73o C  for 2 minutes. (do not do more than 4 slides at a time). Transfer to 2X SSC/0.1% Tween 
20  (pH 7.0) at room temperature ( 59°F to 86°F) for 1 minute. 
 
7. Transfer slides to 1X PBD at room temperature until ready to cover slip.  
 
8. Counterstain with 10 µL of DAPI II and cover slip with a 24 x 50 mm #1 cover slip.  Examine 
slide using fluorescence microscopy.  
Data Collection 
1. Record coordinates of 5 metaphases with specific hybridization signals on a microscope 
analysis sheet.  The patient name and case number are to be “checked” on the scope sheet to 
verify that the patient identifiers coincide with the slides to be scoped. Place a check next to the 
CG# and patient name to verify identification. 
 
2. Capture and print images of the five metaphases using the CytoVision Imaging System. 
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APPENDIX N 
 
FISH ON CULTURED LEUKEMIC BLOOD LYMPHOCYTES AND BONE MARROW 
 
Specimen Processing   (Performed by Bone Marrow Techs) 
 
1. Record sample in FISH/bone marrow log book. 
 
2. Process the specimen according to protocol in the Standard Operating Manual for Bone 
Marrows and Leukemic Bloods. 
 
Slide Making 
 
1. Soak slides in deionized water.  
 
2. Remove tubes with harvested cells from 4OC coldroom. Centrifuge at 1000 rpm for 10 
minutes.  Aspirate supernate to a level slightly above the pellet.  Add 10 mL of fresh fixative (3:1 
methanol:acetic acid) and spin at 1000 rpm for 10 minutes. Aspirate supernate to a level slightly 
above the pellet.  Add fresh fixative to make a slightly turbid cell suspension. 
 
3. Drain excess water from a slide with a paper towel. 
 
4. Use a Pasteur pipette to place two drops of cell suspension per slide from eye level and tap the 
edge of the slide on a paper towel. 
 
5. Check cells using phase contrast microscopy. 
 
6. With a pencil or a Securline Marker II SuperFrost marker (Fisher Scientific), mark each slide 
with the CG #, name, and FISH probe.  Store slides in desiccator at room temperature (59°F to 
86°F) or use them directly for FISH. 
 
FISH  
 
1. Incubate slides for 30 minutes in 2X SSC (pH 7.0) in a coplin jar in a waterbath pre-warmed 
to 37°C.  Dehydrate slides in 70%, 80%, 90%, and 100% ethanol series for 2 minutes in each jar.  
Air dry. 
 
2.  Pre-warm the probes by placing them in the top drawer on the FISH bench for at least 5 
minutes, then spin briefly in the mini centrifuge prior to applying them to the slides.  
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3. Apply 9.5 µL of probe, cover with a 22x30mm cover slip and seal carefully with rubber 
cement, use 22x22mm cover slips if using 2 probes per slide. (If the probe needs to be prepared, 
add 1 µL of the probe and 2 µL of sterile H2O to 7 µL of hybridization buffer. Vortex briefly on 
low, then spin briefly in the mini centrifuge).   
 
4.  Denature probe and cells together at 80oC on the HYBrite slide warmer.  
     *** 1 minute for metaphase spreads 
 *** 2 minutes for interphase cells 
 
5. Incubate overnight at 37oC in the FISH incubator in the tissue culture room. 
 
6. Remove cover slips. Wash slides one time in 0.4X SSC/0.3% Tween 20 (pH 7.0) at 73oC for 2 
minutes and once in 2X SSC/0.1% Tween 20 (pH 7.0) at room temperature for 1 minute. 
 
7. Transfer slides to 1X PBD at room temperature. 
 
8.  Counterstain with 10 µL of DAPI II/Antifade and cover slip with a 24 x 50 mm #1 coverslip.  
Examine slide with fluorescence microscopy.  
 
Data Collection 
 
1. Count number and/or pattern of signals in 100 nuclei (200 nuclei for CpG- stimulated 
cultures) and record on data sheet. The patient name and case number are to be “checked” 
on the scope sheet to verify that the patient identifiers match that of the slides to be 
scoped. Place a check next to the CG# and patient name to verify identification. 
 
2. If results are normal, record images of four nuclei using the CytoVision Imaging System. 
 
3. If results are abnormal, record images of two nuclei per clone or four nuclei if case is 
monoclonal. 
 
4. Print a representative FLEX image from cases with abnormal results. Pictures can be 
printed from normal cases at director's request. 
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APPENDIX O 
 
FISH ON 5 ± 1 µm SECTIONS OF FORMALIN FIXED, PARAFFIN EMBEDDED 
TUMOR TISSUE USING THE THERMOBRITE ELITE (TBE) 
 
(Note: The TBE manufacturer’s user manual and protocol is located in the FISH microscope 
room 5068) 
 
1.  Slide preparation (prepared slides by the BWH Histology Laboratory) 
 a. cut 5 ± 1 µm thick tissue section using microtome 
 b. float the sections in a protein-free (i.e., triple distilled) waterbath at 40oC 
 c. mount the sections on a positively charged slide 
 d. air dry the slides overnight (do not bake). 
e. submit two (2) unbaked, unstained slides and one (1) H&E (Hematoxylin and  Eosin 
stained) slide with a marked   
 FISH target area evaluated by a pathologist to the Cytogenetics Laboratory 
2.  Slide preparation for FISH (performed at the BWH Cytogenetics Laboratory) 
a. wearing gloves, place the slide with paraffin section(s) face down onto a clean  
    H&E slide; align the unstained tissue section(s) to the corresponding tissue area  
    on the H&E slide; make a circle (using diamond pen) around the indicated  
    target tumor area 
b. bake slides at 56oC overnight Note: In the event that the slides are not put on     the 
slide warmer overnight, it is possible but not preferable, to warm the slides for a 
minimum of 2 hours at 56oC. 
3.  Slide deparaffinization and pretreatment 
 a. turn on the TBE (switch is on the back, right side of machine) and laptop 
 b. enter system password (available in FISH microscope room) 
c. wait for system self check procedure to complete 
d. click on “Run/ Create/ Edit”,  
e. under Available Protocols click on “B&W Tissue Pretreatment”  
f. click the “Run” arrow on the bottom of the screen 
g. select the module places for each slide to be loaded, click “Next” 
h. ensure that the reagent bottles are filled to at least the indicated level 
i. remove all tubes from TBE wash solution and dip ends into a beaker containing  500 
mL of fresh distilled water before placing the tubes into the correct reagent bottles. 
j. pour a 250 mg vial of protease into a 500 mL bottle of protease buffer; using a glass 
pipet, vigorously rinse out the protease vial using the buffer solution at least five times, 
invert the reconstituted protease at least thirty times to ensure dissolution, pour the 
protease into the proper reagent bottle 
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k. remove the machine cover, open the black module lid, remove slides from 56oC hot 
plate and load into machine according to selections from step G, ensuring that the 
TISSUE SIDE IS FACING DOWN in the slide holder and that the ends of the slide are 
securely clicked into place, place slide holder into module, close module lid, replace 
top cover 
l. double check that the lines are connected to the machine properly 
m. check the box indicating that the configuration has been confirmed 
n. enter initials and click “Start Protocol” to begin the protocol 
o. when protocol is completed, remove slides, allow to air dry, soak up any excess 
moisture within the modules using an absorbent wipe, select “Save Notes and Close”, 
select “Next” 
4.  Hybridization 
a. bring desired FISH probes to room temperature in the dark 
b. click on “Run/ Create/ Edit”,  
c. under Available Protocols click on “B&W Tissue Hybe”  
d. click the “Run” arrow on the bottom of the screen 
e. select the module places where the slides will be loaded, click “Next” 
f. ensure that the reagent bottles are filled to the indicated level or above 
g. hybridize slides 
- apply 3.0 µL, 6.0 µL, 10 µL or 15 µL of the probe to the center of the   
  marked area to be covered by a 12 mm circle, a 18x18 mm square, a  
  22x22 mm square or 22x30 mm rectangle coverslip 
- place cover slip on top of the probe mixture; allow mixture to spread evenly 
under the cover slip. Avoid air bubbles. 
- seal coverslip with rubber cement 
h. place slides in slide holders TISSUE SIDE FACING UP, load into modules,   close 
module lid and replace top cover 
g. double check that the lines are connected to the machine properly 
h. check the box indicating that the configuration has been confirmed 
i. enter initials and click “Start Protocol” to begin the protocol 
j. the next day, resume the protocol and it will finish after 1 minute, select “Save Notes 
and Close”, select “Next” 
5. Post-hybridization wash 
a. click on “Run/ Create/ Edit”, 
b. under Available Protocols click on “B&W Tissue Post Treatment” 
c. click the “Run” arrow on the bottom of the screen 
d. select the module places where the slides will be loaded, click “Next” 
e. ensure that the reagent bottles are filled to at least the indicated level 
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f. remove slides from modules, wipe off excess water from the back of each slide, then 
gentle lay the tissue side of each slide on an absorbent wipe in order to blot off any 
water from the front of the slide 
g. gently remove the rubber cement seal from around the cover slip and slide the   cover 
slip off of the slide, if the cover slip will not slide off easily, immerse slides in post-
hybridization wash buffer at RT for 12 min to float off the coverslips 
h. place slides in slide holders TISSUE SIDE FACING DOWN, load into modules, close 
module lid and replace top cover 
i. double check that the lines are connected to the machine properly 
j. check the box indicating that the configuration has been confirmed 
k. enter initials and click “Start Protocol” to begin the protocol 
l. upon protocol completion, remove slides from TBE and allow to air dry in the dark, 
select “Save Notes and Close”, select “Next” 
m. apply 15 µL of DAPI counterstain, cover with 22x50 #1 coverslip 
n. store slides in dark at -20oC for at least one hour 
o. pre-warm to room temperature (59°F to 86°F) before microscope examination 
6. Line wash 
a. select “Line Wash”, ensure that only biocompatible lines are checked 
    NOTE:  Never wash any line used for xylene or xylene substitute 
b. dip lines to be washed in 500 mL of dH2O before placing in wash solution 
c. click “Start”, after confirming the setup, click “Yes” 
d. when prompted, remove lines from wash solution and click “Resume” 
e. when wash is completed, select “Save Notes and Close, place lines back into wash 
solution, select “Next” 
f. cover any uncapped reagent bottle with parafilm 
g. shutdown laptop and turn off the TBE 
h. lift the covers of both peristaltic pumps to relieve pressure on the tubing 
7. Waste disposal 
 - Dispose of any bottle contents when half full 
- Dispose of the contents of bottle A into the properly labeled carboy 
- Dispose of the contents of bottle B in the wet lab sink  
- Dispose of the contents of bottle C into a red 5 gallon Biohazard tagged waste container 
with the proper tag. 
8. Assess slide adequacy 
- signal intensity: signals should be bright, compact, distinct and easy  
  to evaluate 
- background:  background should appear dark and relatively free of  
  autofluorescence  
9. Select target areas 
- use DAPI filter first, identify the marked target area(s).  Tumor cells, in  
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  general, are larger than normal cells (e.g., lymphocytes) 
- select optimal area(s) for evaluation.  Skip necrotic areas, and areas with  
  weak or non-specific signals, or with an excess of background.  Skip   
  cells with insufficient counterstain to determine the nuclear borders 
- scan several areas of tumor cells to evaluate for  possible heterogeneity. 
  Begin analysis in upper left quadrant of selected area, scan from left to  
  right.  Count number of signals of each individual nucleus. 
10. Reading and scoring criteria 
  - focus up and down to find all signals present in the nucleus 
  - count two signals of the same color that are the same size and separated  
                          by a distance equal to or less than the signal diameter as ONE signal 
 
Note: For evaluation of ALK rearrangement in lung tumor cells, the green signal must be 
separated from the red signal by a distance greater than TWO signal diameters to be 
considered split.  For all other break-apart probes (e.g., NUT) the distance should be equal to or 
greater than ¼ diameter of the evaluated nucleus. 
For BRAF rearrangement in brain tumor cells, evaluate individual nuclei for the copy number 
of BRAF, specifically the presence/absence of a duplication event involving the 3' region of 
BRAF (RED doublets) and for the copy number of chromosome 7 (aqua signals). 
   
- Do NOT score nuclei with the signals of only one color 
  - Do NOT score nuclei with ambiguous borders or with overlapped 
                           borders.   
  - Do NOT evaluate nuclei that are not intact 
- Do NOT evaluate nuclei with signals located on the periphery of the  
  nucleus  
- Do alternate between DAPI, Green, Red, Aqua, Red/Green and DAPI/red/green 
filters to better evaluate signals 
10. Minimum number of nuclei to be scored for a complete analysis 
- for BRAF, score 100 random nuclei from throughout specimen  (50 
nuclei/reader) 
- for all other probes, score 50 nuclei (25 nuclei/reader) 
  from two separate areas of tumor 
- record counts and hybridization patterns on a scope sheet 
- capture images of four representative nuclei for documentation 
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TBE Tissue Protocol 
 
 
 
From the "Available Protocols" menu select : 
A) Pretreatment 
1. Drain 
2. Hemo-De, ( Fill, Flush 35 mL of 100% Ethanol),Rock med,  Incubate 10 minutes, Drain 
3. Hemo-De, (Fill, Flush 35 mL of 100% Ethanol), Rock med, Incubate  10 minutes, Drain 
4. Hemo-De, (Fill, Flush 35 mL of 100% Ethanol), Rock med, Incubate 10 minutes, Drain 
5. 100% Ethanol ,Fill, Rock med, Incubate 5 minutes, Drain 
6. 100% Ethanol, Fill ,Rock med, Incubate 5 minutes, Drain 
7. 0.2NHCL, (Fill, Flush 35 mL of dH20),Rock med, Incubate  20 minutes, Drain 
8. dH20, Fill, Rock med, Incubate 3 minutes, Drain 
9. 2XSSC, Fill, Rock med, Incubate  3 minutes, Drain, Flush 35mL of dH2O 
10. Pre-Treatment Solution, (Fill, Flush 35 mL of dH2O), Rock med  BC Temp 65°C, wait 
Yes 0.3 minutes, Temp 80°C, wait Yes Incubate 30 minutes,  Drain 
11. dH2O, Fill, Rock med, Temp 25°C, No Wait, Drain  
12. dH2O, Fill, Rock med, Incubate 1 minute, Drain 
13. 2XSSC, Fill, Rock med, Incubate 5 minutes, Drain 
14. 2XSSC, Fill, Rock med, Incubate  5 minutes, Drain 
15. Protease, (Fill, Flush 35 mL of dH20), Rock med, Temp 37°C wait Yes, Incubate 37  
minutes, Drain 
16. 2XSSC,Fill, Rock med, Incubate  5 minutes, Drain 
17. 2XSSC,Fill, Rock med, Incubate  5 minutes, Drain 
18. 10% Neutral Buffered Formalin, Fill, Rock med, Incubate 10 minutes, Drain 
19. 2XSSC, Fill, Rock med, Incubate 5 minutes, Drain 
20. 2XSSC, Fill, Rock med, Incubate 5 minutes, Drain 
21. 70% Ethanol, Fill, Rock med, Incubate 1 minutes, Drain 
22. 85% Ethanol, Fill, Rock med, Incubate 1 minutes, Drain 
23. 100% Ethanol, Fill, Rock med, Incubate 1 minutes, Drain 
-OFFLINE- 
24. Dry slides completely. 
25. Pipette probe on coverslip and mount to slide.  
26. Apply rubber cement sealant.  
B) Denature & Hybe 
1. Drain 
2. Fill 50% d H20, Rock med,  Temp 65°C wait  yes 0.3min, Temp 80°C wait  yes, incubate 
6 min, Temp 60° wait yes, Drain 
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3. Temp 37°C No Wait,  Fill 50%d H20, Rock med, Temp 37°C,wait Yes, Incubate 960 
min(16 hrs)  Prompt pause Y “hold hybe”  Drain 
C) Post Wash 
1.  Drain 
2. 2XSSC+0.3%NP-40, Fill, Rock med, Temp  62°C wait Yes  Incubate 0.3 minutes, Temp 
71°C, Wait Yes , Incubate 2 minutes, Temp 60°C, Wait Yes, Temp 25°C Wait No, Drain 
-Offline- 
3. Dry slides completely.  
4. Apply mounting medium (DAPI) to target area and apply cover slip.  
 
TBE Troubleshooting 
 
When reagent flow rates are reduced, the system generates flow rate errors.  These are usually 
caused by inadequate peristaltic pump tubing (see instructions on replacing tubing in TBE 
manufacturer's User Manual).  If the flow rate gets low enough, a critical error will be generated 
which can abort the protocol if the error is not manually ignored by an operator.  In cases where 
the TBE protocol aborts, the protocol must be restarted from the step where termination 
occurred; this is accomplished by the following steps: 
 
1. When the protocol aborts, there will be a window on the left of the display that shows the 
current step being performed when termination occurred.  Write down this step. 
 
2.  In the error window, select “Drain Chambers”, when chambers are drained, select “Save 
Notes and Close”, select “Next”, then click on “Run/Create/Edit” 
 
3. From the “Available Protocols” list select the protocol that aborted, select 'Copy'.  This creates 
a new file with the same protocol steps. 
 
4.  In the “Protocol Steps” window, delete every step prior to the step being performed when 
protocol aborted (this was written down in step 1 above). 
 
5.  Click “next”, then “Save”.  Run the newly created protocol. 
 
 
NOTE: Please see the TBE manufacturer’s User Manual for additional troubleshooting 
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APPENDIX P 
 
FISH ON INTERPHASE NUCLEI - MICROSCOPE SLIDE EVALUATION AND 
SIGNAL SCORING 
1.  Assess slide adequacy 
     Screen entire hybridized area for: 
 - Signal intensity: signals should be bright, compact, distinct and easy to evaluate 
 - Background: look for areas with no or low background noise  
2.  Select slide area(s) for evaluation 
 - skip area with non-specific signals or excess background 
 - skip cells with insufficient DAPI counterstain to determine the nuclear borders 
 - skip cell clusters or cells with overlaps 
3.  Reading, scoring and image capture 
Please note: all interphase FISH tests must be read by two validated technologists in the 
following instances: 
a. Cases for which there is no accompanying karyotype: paraffin blocks, smears, and 
touch preps  
b. Cases for which there is an uninformative karyotype: normal, no metaphases, or few 
metaphases but pathology report describes an abnormal finding 
c. Cases for which no karyotype was obtained: no growth or no metaphases 
-begin analysis in upper left or right quadrant of selected area of slide, scan from left to 
right or right to left 
- focus up and down to find all signals present in the nucleus 
- alternate between DAPI, Green, Red, Aqua, Red/Green, DAPI/Red/Green filters to 
better evaluate signals in nuclei hybridized with multicolor probes 
- do NOT score nuclei with NO signal or signals for only one color 
- do NOT score nuclei with ambiguous borders or clusters or overlaps 
- do NOT evaluate nuclei which are NOT intact 
- do NOT evaluate nuclei with signals located on the periphery of the nucleus 
-  count and record number of signals or hybridization pattern in each of randomly 
selected individual nuclei 
- for copy number evaluation (e.g., evaluation for aneuploidy of chromosomes 13, 18, 21, 
X, Y in CVS/amniotic fluid cells) count two signals of the same color that are the same 
size and separated by a distance equal to or less than the signal diameter as ONE 
signal. 
- for rearrangement of a particular gene of interest (break-apart probes) the distance 
between red and green signals should be equal to or greater than ¼ the diameter of 
the individual nucleus 
 
Note: For additional information regarding scoring criteria, see also the FISH protocol for 5 micron 
tissue sections.  
